{"id":26979,"date":"2026-03-29T13:53:16","date_gmt":"2026-03-29T10:53:16","guid":{"rendered":"https:\/\/asmarya.edu.ly\/pharmacy\/?page_id=26979"},"modified":"2026-03-30T10:05:15","modified_gmt":"2026-03-30T07:05:15","slug":"%d8%aa%d9%88%d8%b5%d9%8a%d9%81-%d8%a7%d9%84%d9%85%d9%82%d8%b1%d8%b1%d8%a7%d8%aa-%d8%a7%d9%84%d8%af%d8%b1%d8%a7%d8%b3%d9%8a%d8%a9-%d9%84%d9%82%d8%b3%d9%85-%d9%84%d8%a7%d8%b1%d8%b9%d8%a7%d9%8a%d8%a9","status":"publish","type":"page","link":"https:\/\/asmarya.edu.ly\/pharmacy\/?page_id=26979","title":{"rendered":"\u062a\u0648\u0635\u064a\u0641 \u0627\u0644\u0645\u0642\u0631\u0631\u0627\u062a \u0627\u0644\u062f\u0631\u0627\u0633\u064a\u0629 \u0644\u0642\u0633\u0645 \u0627\u0644\u0631\u0639\u0627\u064a\u0629 \u0627\u0644\u0635\u064a\u062f\u0644\u0627\u0646\u064a\u0629"},"content":{"rendered":"[mhc_section admin_label=&#8221;\u0642\u0633\u0645&#8221; fullwidth=&#8221;on&#8221; specialty=&#8221;off&#8221;][mhc_fullwidth_texton admin_label=&#8221;\u0645\u0644\u0635\u0642 \u0628\u0639\u0631\u0636 \u0643\u0627\u0645\u0644&#8221; src=&#8221;https:\/\/asmarya.edu.ly\/pharmacy\/wp-content\/uploads\/2026\/03\/\u0648\u0635\u0641-\u0627\u0644\u0645\u0642\u0631\u0631\u0627\u062a-\u0627\u0644\u062f\u0631\u0627\u0633\u064a\u0629-1.webp&#8221; text_placement=&#8221;right_bottom&#8221; text_size=&#8221;xl&#8221; text_color=&#8221;#ffffff&#8221; url_new_window=&#8221;off&#8221; background_color=&#8221;#121212&#8243; text_shadow=&#8221;off&#8221; use_button=&#8221;off&#8221; button_style=&#8221;off&#8221; button_color=&#8221;#0b0b21&#8243; button_text_color=&#8221;#ffffff&#8221; wide_button=&#8221;off&#8221; sticky=&#8221;off&#8221; animation=&#8221;off&#8221; hoverfx=&#8221;scaleup&#8221;] [\/mhc_fullwidth_texton][\/mhc_section][mhc_section admin_label=&#8221;\u0642\u0633\u0645&#8221; fullwidth=&#8221;off&#8221; specialty=&#8221;off&#8221; transparent_background=&#8221;off&#8221; gradient_background=&#8221;off&#8221; background_color=&#8221;#ffffff&#8221; gradient_style=&#8221;horizontal&#8221; inner_shadow=&#8221;off&#8221; parallax=&#8221;off&#8221; parallax_method=&#8221;off&#8221; video_hide=&#8221;off&#8221; video_pause=&#8221;off&#8221; allow_advanced_padding=&#8221;on&#8221; remove_padding=&#8221;on&#8221; force_fullwidth=&#8221;off&#8221; column_paddings=&#8221;padding-0pct&#8221; column_match_heights=&#8221;off&#8221; background_leak=&#8221;off&#8221; background_leak_color=&#8221;#ffffff&#8221; background_leak_size=&#8221;50&#8243; separator_top=&#8221;off&#8221; separator_bottom=&#8221;off&#8221; background_image_size=&#8221;cover&#8221; background_image_repeat=&#8221;no-repeat&#8221; background_image_position_x=&#8221;center&#8221; background_image_position_y=&#8221;center&#8221; animation=&#8221;off&#8221; animation_color=&#8221;#ffffff&#8221; mobile_2_pr_row=&#8221;off&#8221; mobile_reverse=&#8221;off&#8221;][mhc_row admin_label=&#8221;\u0635\u0641&#8221;][mhc_column type=&#8221;4_4&#8243;][mhc_divider admin_label=&#8221;\u0641\u0627\u0635\u0644&#8221; show_divider=&#8221;off&#8221; color=&#8221;#4FD4FF&#8221; borderw=&#8221;1&#8243; custom_orientation=&#8221;right&#8221; height=&#8221;10&#8243; divider_style=&#8221;solid&#8221; keep_visible=&#8221;off&#8221; custom_radius=&#8221;on&#8221; animation=&#8221;off&#8221;] [\/mhc_divider][mhc_text admin_label=&#8221;\u0627\u0644\u0631\u0626\u064a\u0633\u064a\u0629 \u00bb \u0627\u0644\u0623\u0642\u0633\u0627\u0645 \u0627\u0644\u0639\u0644\u0645\u064a\u0629 \u00bb \u0642\u0633\u0645 \u0627\u0644\u0631\u0639\u0627\u064a\u0629 \u0627\u0644\u0635\u064a\u062f\u0644\u0627\u0646\u064a\u0629 \u00bb \u0627\u0644\u0645\u0642\u0631\u0631\u0627\u062a \u0627\u0644\u062f\u0631\u0627\u0633\u064a\u0629&#8221; background_layout=&#8221;light&#8221; text_orientation=&#8221;right&#8221; animation=&#8221;off&#8221;]\n<p><span style=\"font-size: 16px;\"><a href=\"https:\/\/asmarya.edu.ly\/pharmacy\/\">\u0627\u0644\u0631\u0626\u064a\u0633\u064a\u0629<\/a> \u00bb <a href=\"https:\/\/asmarya.edu.ly\/pharmacy\/?page_id=1803\">\u0627\u0644\u0623\u0642\u0633\u0627\u0645 \u0627\u0644\u0639\u0644\u0645\u064a\u0629<\/a> \u00bb<a href=\"https:\/\/asmarya.edu.ly\/pharmacy\/?page_id=25517\"> \u0642\u0633\u0645 \u0627\u0644\u0631\u0639\u0627\u064a\u0629 \u0627\u0644\u0635\u064a\u062f\u0644\u0627\u0646\u064a\u0629\u00a0<\/a>\u00bb \u062a\u0648\u0635\u064a\u0641 \u0627\u0644\u0645\u0642\u0631\u0631\u0627\u062a<\/span><\/p>\n[\/mhc_text][\/mhc_column][\/mhc_row][\/mhc_section][mhc_section admin_label=&#8221;\u0642\u0633\u0645&#8221; fullwidth=&#8221;off&#8221; specialty=&#8221;off&#8221;][mhc_row admin_label=&#8221;row&#8221;][mhc_column type=&#8221;4_4&#8243;][mhc_text admin_label=&#8221;\u0646\u0635 &#8211; Pathology (\u0639\u0644\u0645 \u0627\u0644\u0623\u0645\u0631\u0627\u0636)&#8221; background_layout=&#8221;light&#8221; text_orientation=&#8221;right&#8221; animation=&#8221;off&#8221;]\n<p><strong>Pathology (\u0639\u0644\u0645 \u0627\u0644\u0623\u0645\u0631\u0627\u0636)<br \/>\n\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640<\/strong><\/p>\n[\/mhc_text][mhc_tabs admin_label=&#8221;\u062a\u0628\u0648\u064a\u0628 &#8211; Pathology (\u0639\u0644\u0645 \u0627\u0644\u0623\u0645\u0631\u0627\u0636)&#8221; background_layout=&#8221;light&#8221; show_border=&#8221;on&#8221;] [mhc_tab title=&#8221;\u0631\u0645\u0632 \u0627\u0644\u0645\u0642\u0631\u0631&#8221;]\n<ul>\n<li>(PH206)<\/li>\n<\/ul>\n[\/mhc_tab][mhc_tab title=&#8221;\u0639\u062f\u062f \u0627\u0644\u0648\u062d\u062f\u0627\u062a&#8221;]\n<ul>\n<li><strong>3 Units<\/strong><\/li>\n<\/ul>\n[\/mhc_tab][mhc_tab title=&#8221;\u0639\u062f\u062f \u0627\u0644\u0633\u0627\u0639\u0627\u062a \u0627\u0644\u0623\u0633\u0628\u0648\u0639\u064a\u0629&#8221;]\n<ul>\n<li><strong>2 hrs Theory<\/strong><\/li>\n<li><strong>2 hrs Laboratory<\/strong><\/li>\n<\/ul>\n[\/mhc_tab][mhc_tab title=&#8221;\u0646\u0648\u0639 \u0627\u0644\u0645\u0642\u0631\u0631&#8221;]\n<ul>\n<li><strong>General<\/strong><\/li>\n<\/ul>\n[\/mhc_tab][mhc_tab title=&#8221;\u0627\u0644\u0623\u0633\u0628\u0642\u064a\u0629&#8221;]\n<ul>\n<li><strong>Physiology<\/strong><\/li>\n<\/ul>\n[\/mhc_tab][mhc_tab title=&#8221;\u0648\u0635\u0641 \u0627\u0644\u0645\u0642\u0631\u0631&#8221;]\n<ul>\n<li><strong>Course Description:\u00a0\u00a0 <\/strong><strong>(\u0648\u0635\u0641 \u0627\u0644\u0645\u0642\u0631\u0631)<\/strong>\n<p style=\"text-align: left;\"><strong>Brief Description:<\/strong><\/p>\n<p style=\"text-align: left;\">The Pathology module is divided into two parts- general pathology and systemic pathology. It is designed to cover the following topics: cellular injury and adaptation, acute and chronic inflammation, regeneration and repair, circular disturbance, disturbances of cell growth. The students also study in this subject the Pathology of the immune reaction, bacterial and protozoal diseases, tumor pathology and endocrine CVS, GIT, respiratory and urinary.<\/p>\n<p style=\"text-align: left;\"><strong>Course Objectives:<\/strong><\/p>\n<p style=\"text-align: left;\">The broad objectives of the module were for the students to understand the etiology, pathogenesis and key morphological and clinical features of major disease conditions, as well as to correlate these with the fundamental principles of therapy.<\/p>\n<p style=\"text-align: left;\"><strong>Generic Skills:<\/strong><\/p>\n<p style=\"text-align: left;\">The faculty is committed to ensuring that students have the full range of knowledge and skills required for full participation in all aspects of their lives, including skills enabling them to be life-long learners. To ensure graduates have this preparation, such generic skills as literacy and numeric, computer, interpersonal communications, and critical thinking skills will be embedded<\/p>\n<p style=\"text-align: left;\">in all courses.<\/p>\n<p style=\"text-align: left;\"><strong>Attendance Expectations:<\/strong><\/p>\n<p style=\"text-align: left;\">Students are expected to attend every session of class, arriving on time, returning from breaks promptly and remaining until class is dismissed. Absences are permitted only for medical reasons and must be supported with a doctor\u2019s note.<\/p>\n<p style=\"text-align: left;\"><strong>\u00a0<\/strong><\/p>\n<p style=\"text-align: left;\"><strong>Content Breakdown:<\/strong><\/p>\n<table class=\" alignleft\" width=\"100%\">\n<tbody>\n<tr>\n<td width=\"28%\"><strong>Session\\Week<\/strong><\/td>\n<td width=\"71%\"><strong>Topical Coverage<\/strong><\/td>\n<\/tr>\n<tr>\n<td width=\"28%\"><strong>Session 1(Week 1)<\/strong><\/td>\n<td width=\"71%\"><strong>General Pathology:<\/strong><\/p>\n<p><strong>Unit I: Cellular response to injury:<\/strong><\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Causes of cell injury.<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Mechanism of cell injury.<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Morphological alteration in cell injury.<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Necrosis (pathological cell&#8217;s death): Coagulative, Gaseous necrosis, liquifactive, fat, Zenker&#8217;s necrosis.<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Apoptosis.<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Gangrene<\/td>\n<\/tr>\n<tr>\n<td width=\"28%\"><strong>Session 2 (Week 2)<\/strong><\/td>\n<td width=\"71%\"><strong>Unit II: Intracellular accumulation and Extracellular depositions: Intracellular accumulation:<\/strong><\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Steatosis (fatty change)<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Cholesterol and cholesterol esters<\/p>\n<p><strong>Extracellular depositions:<\/strong><\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Pathological calcification<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Amyloidois<\/td>\n<\/tr>\n<tr>\n<td width=\"28%\"><strong>Session 3 (Week 3)<\/strong><\/td>\n<td width=\"71%\"><strong>Unit III: Cellular adaptations\/ growth disturbances:<\/strong><\/td>\n<\/tr>\n<tr>\n<td width=\"28%\"><strong>Session 4 (Week 4)<\/strong><\/td>\n<td width=\"71%\"><strong>Unit IV: inflammation:<\/strong><\/p>\n<p><strong>Acute inflammation:<\/strong><\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Definition<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 local signs and symptoms, systemic effects<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 outcomes of acute inflammation<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 types of acute inflammation<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 abscess, furuncle, carbuncle,<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 serous inflammation, fibrinous inflammation<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 chemical mediators and regulators of inflammation<\/td>\n<\/tr>\n<tr>\n<td width=\"28%\"><strong>Session 5 (Week 5)<\/strong><\/td>\n<td width=\"71%\"><strong>Chronic inflammation, repair and cell injury:<\/strong><\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Definition<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Cells of chronic inflammation,<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Types of chronic inflammation, granuloma,<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Healing and repair<\/td>\n<\/tr>\n<tr>\n<td width=\"28%\"><strong>Session 6 (Week 6)<\/strong><\/td>\n<td width=\"71%\"><strong>Unit V: Regeneration and repair:<\/strong><\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Healing of wounds: (Primary and secondary types, Factors affecting wound healing)<\/td>\n<\/tr>\n<tr>\n<td width=\"28%\"><strong>Session 7 (Week 7)<\/strong><\/td>\n<td width=\"71%\"><strong>Unit V: circulatory disturbances:<\/strong><\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Edema: definition, types, pathogenesis.<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Embolism: definition, types.<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Infarction: definition, types.<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Hemorrhage and shock: mechanism and types.<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Congestion: active and passive.<\/td>\n<\/tr>\n<tr>\n<td width=\"28%\"><strong>Session 8 (Week 8)<\/strong><\/td>\n<td width=\"71%\"><strong>Unit VI: Disturbances of cell growth:<\/strong><\/p>\n<p>\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Aplasia -Hypoplasia. &#8211; Hyperplasia. &#8211; Atrophy. &#8211; Hypertrophy.<\/p>\n<p>\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Hematoma. &#8211; Metaplasia.- Anaplasia.<\/td>\n<\/tr>\n<tr>\n<td width=\"28%\"><strong>Session 9 (Week 9)<\/strong><\/td>\n<td width=\"71%\"><strong>Unit VII: General tumor pathology:<\/strong><\/p>\n<p>\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Neoplasia (tumors): Definition, classification, differences between benign and malignant tumors, types of benign and malignant tumors, malignancies of hematopoietic cells. (Leukemia) and lymphomas.<\/td>\n<\/tr>\n<tr>\n<td width=\"28%\"><strong>Session 10 (Week 10)<\/strong><\/td>\n<td width=\"71%\">\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Carcinogenesis: Clinical aspects of tumors, diagnosis of cancer, cancer arraigning and staging.<\/td>\n<\/tr>\n<tr>\n<td width=\"28%\"><strong>Session 11 (Week 11)<\/strong><\/td>\n<td rowspan=\"4\" width=\"71%\"><strong>Midterm Assessment<\/strong><\/td>\n<\/tr>\n<tr>\n<td width=\"28%\"><strong>Session 12 (Week 12)<\/strong><\/td>\n<\/tr>\n<tr>\n<td width=\"28%\"><strong>Session 13 (Week 13)<\/strong><\/td>\n<\/tr>\n<tr>\n<td width=\"28%\"><strong>Session 14 (Week 14)<\/strong><\/td>\n<\/tr>\n<tr>\n<td width=\"28%\"><strong>Session 15 (Week 15)<\/strong><\/td>\n<td width=\"71%\"><strong>Unit VIII: Pathology of the immune reaction:<\/strong><\/p>\n<p>\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Introduction to the immune system.<\/p>\n<p>\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Cells and other elements involved in the immune response (T,B \u2026cells)<\/p>\n<p>\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Hypersensitivity reactions; types (I, II,III, IV).<\/td>\n<\/tr>\n<tr>\n<td width=\"28%\"><strong>Session 16 (Week 16)<\/strong><\/td>\n<td width=\"71%\">\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 HLA system.<\/p>\n<p>\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Transplant pathology.<\/p>\n<p>\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Auto-immune diseases: Types, etiology, pathogenesis, clinical features, pathology and prognosis of selected major illness (SLE, Scleroderma).<\/p>\n<p>\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Acquired immune deficiency syndromes.<\/td>\n<\/tr>\n<tr>\n<td width=\"28%\"><strong>Session 17 (Week 17)<\/strong><\/td>\n<td width=\"71%\"><strong>Unit<\/strong> <strong>IX:<\/strong> <strong>Infections:<\/strong><\/p>\n<p>\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Tuberculosis: incidence, pathogenesis, primary complex secondary TB and features of pulmonary TB.<\/td>\n<\/tr>\n<tr>\n<td width=\"28%\"><strong>Session 18 (Week 18)<\/strong><\/td>\n<td width=\"71%\">\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Syphilis: Mode of transmission, stages, signs and symptoms, organs involved and effects. Congenital syphilis.<\/p>\n<p>\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Gonorrhea:<\/p>\n<p><strong>Unit X: Protozoal and Helminithic diseases:<\/strong><\/p>\n<p>\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Amoebiasis, Leishmaniasis, Hydatid disease.<\/td>\n<\/tr>\n<tr>\n<td width=\"28%\"><strong>Session 19 (Week 19)<\/strong><\/td>\n<td width=\"71%\">\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Malaria.<\/p>\n<p>\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Bilharzisis: Geographical distribution, types, and complications.<\/td>\n<\/tr>\n<tr>\n<td width=\"28%\"><strong>Session 20 (Week 20)<\/strong><\/td>\n<td width=\"71%\"><strong>Systemic Pathology:<\/strong><\/p>\n<p><strong>Unit XI: Cardiovascular system:<\/strong><\/p>\n<p>\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Atherosclerosis- pathogenesis, risk factors, complications.<\/p>\n<p>\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Hypertension.<\/p>\n<p>\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Ischemic heart disease (IHD)- types of angina pectoris, rheumatic heart disease.<\/p>\n<p>\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Iinfective endocarditis.<\/td>\n<\/tr>\n<tr>\n<td width=\"28%\"><strong>Session 21 (Week 21)<\/strong><\/td>\n<td width=\"71%\"><strong>Unit XII: Respiratory system:<\/strong><\/p>\n<p>\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Tonsillitis, bronchitis, bronchial asthma, pneumonia- bronchiectasis-<\/p>\n<p>\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Bronchogenic carcinoma.<\/td>\n<\/tr>\n<tr>\n<td width=\"28%\"><strong>Session 22 (Week 22)<\/strong><\/td>\n<td width=\"71%\"><strong>Unit XIII: Gastro-intestinal system:<\/strong><\/p>\n<p>\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Gastritis-Peptic Ulcer, Ulcerative colitis, Crohn&#8217;s disease, Zollinger- Ellison syndrome, Pancreatitis<\/td>\n<\/tr>\n<tr>\n<td width=\"28%\"><strong>Session 23 (Week 23)<\/strong><\/td>\n<td width=\"71%\"><strong>Unit<\/strong> <strong>XIV:<\/strong> <strong>Biliary<\/strong> <strong>system<\/strong> <strong>and<\/strong> <strong>liver:<\/strong><\/p>\n<p>\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Cholecystitis- Hepatitis- Cirrhosis- complications.<\/td>\n<\/tr>\n<tr>\n<td width=\"28%\"><strong>Session 24 (Week 24)<\/strong><\/td>\n<td width=\"71%\"><strong>Unit XV: Urinary system:<\/strong><\/p>\n<p>\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Glomerulonephritis: definition, types.<\/p>\n<p>\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Drug-nephritic syndrome-induced tubule- cystitis \u2013 interstitial nephritis pyelonephritis.<\/td>\n<\/tr>\n<tr>\n<td width=\"28%\"><strong>Session 25 (Week 25)<\/strong><\/td>\n<td width=\"71%\"><strong>Unit XVI: Endocrine system:<\/strong><\/p>\n<p>\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Thyroid: hypethyroidism, hypothyroidism goiter, pyelonephritis-diabetes mellitus, types, complications<\/p>\n<p>\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Adrenal glands.<\/td>\n<\/tr>\n<tr>\n<td width=\"28%\"><strong>Session 26 (Week 26)<\/strong><\/td>\n<td width=\"71%\"><strong>Unit XVII: Hematopoietic system:<\/strong><\/p>\n<p>\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Classification of anaemias- Iron deficiency anemia \u2013 Vitamin B12 and folate deficiency anaemia- aplastic anaemia- thrombocytopenia- leucopenia.<\/td>\n<\/tr>\n<tr>\n<td width=\"28%\"><strong>Session 27 (Week 27)<\/strong><\/td>\n<td width=\"71%\"><strong>Unit XVIII: Genetic mechanism of diseases:<\/strong><\/p>\n<p>\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Structure of the genom and its disorders, selected definitions, mutationof genes, mendelian disorders, Normal karyo type, cytogenetic disorders, role of moleuclar diagnostics.<\/td>\n<\/tr>\n<tr>\n<td width=\"28%\"><strong>Session 28 (Week 28)<\/strong><\/td>\n<td width=\"71%\">Review<\/td>\n<\/tr>\n<tr>\n<td width=\"28%\"><strong>Practical work<\/strong><\/td>\n<td width=\"71%\">List of Museum specimens:<\/p>\n<p>\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Fibrinous pericarditis, Diphtheria lf larynx, Brain abscess, acute appendicitis<\/p>\n<p>\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Infarction of spleen, CVC liver, Cerebral hemorrhage.<\/p>\n<p>\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Adenoma thyroid, Fibroadenoma Breast (Carcinoma stomach, Carcinoma Ureter).<\/p>\n<p>\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Lipoma (Leiomyoma Uterus, Metastasis Lung, Malignant Melanoma skin).<\/p>\n<p>\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Miliary Tuberculosis, lung (Tuberculosis lymphadenitis, Gumma liver- Bilharzial Hepatic fibrosis- Tuberculosis small intestine- Hydatid cyst liver, Amebic liver abscess).<\/p>\n<p>\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Acute bacterial endocarditis (recent infection heat, Atheresclerosis, Lobar pneumonia, Bronchogenic carcinoma.<\/p>\n<p>\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Crohn&#8217;s disease, Ulcerative colitis-Micro-nodular cirrhosis- Macro-nodular cirrhosis- Chronic cholecystitis- Chronic gastric ulcer.<\/p>\n<p>\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Acute pyelonephritis, Acute cystitis, Goiter.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p style=\"text-align: left;\"><strong>\u00a0<\/strong><\/p>\n<p style=\"text-align: left;\"><strong>Delivery:<\/strong><strong>\u00a0\u00a0\u00a0 <\/strong><\/p>\n<ul style=\"text-align: left;\">\n<li>Lecture-based, Group interaction and discussion, Use of video technique, practical classes.<\/li>\n<\/ul>\n<p style=\"text-align: left;\"><strong>Course Assessments:<\/strong><\/p>\n<ul style=\"text-align: left;\">\n<li>20% Assessment Exam<\/li>\n<li>10% in lab activities<\/li>\n<li>10% in class activities. e.g.: quizzes, reports<\/li>\n<li>40% Final theoretical exam<\/li>\n<li>20 % Final Practical Exam<\/li>\n<li>Total 100%<\/li>\n<\/ul>\n<p style=\"text-align: left;\"><strong>\u00a0<\/strong><\/p>\n<p style=\"text-align: left;\"><strong>Textbooks:<\/strong><\/p>\n<ul>\n<li style=\"text-align: left;\">Pathology and therapeutics for Pharmacists: Green &amp; Harris, Pharmaceutical Press.<\/li>\n<li style=\"text-align: left;\">Rubin&#8217;s Pathology, Clinicopathologic Foundations of Medicine, 6th edition, 2011 edited by Rubin, Strayer, and Rubin (Lippincott Williams and Wilkins).<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n[\/mhc_tab] [\/mhc_tabs][\/mhc_column][\/mhc_row][mhc_row admin_label=&#8221;row&#8221;][mhc_column type=&#8221;4_4&#8243;][mhc_text admin_label=&#8221;\u0646\u0635 &#8211; Hospital Pharmacy (\u0635\u064a\u062f\u0644\u0629 \u0645\u0633\u062a\u0634\u0641\u064a\u0627\u062a)&#8221; background_layout=&#8221;light&#8221; text_orientation=&#8221;right&#8221; animation=&#8221;off&#8221;]\n<p><strong>Hospital Pharmacy (\u0635\u064a\u062f\u0644\u0629 \u0645\u0633\u062a\u0634\u0641\u064a\u0627\u062a)<br \/>\n\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640<\/strong><\/p>\n[\/mhc_text][mhc_tabs admin_label=&#8221;\u062a\u0628\u0648\u064a\u0628 &#8211; Hospital Pharmacy (\u0635\u064a\u062f\u0644\u0629 \u0645\u0633\u062a\u0634\u0641\u064a\u0627\u062a)&#8221; background_layout=&#8221;light&#8221; show_border=&#8221;on&#8221;] [mhc_tab title=&#8221;\u0631\u0645\u0632 \u0627\u0644\u0645\u0642\u0631\u0631&#8221;]\n<ul>\n<li>(PH308)<\/li>\n<\/ul>\n[\/mhc_tab][mhc_tab title=&#8221;\u0639\u062f\u062f \u0627\u0644\u0648\u062d\u062f\u0627\u062a&#8221;]\n<ul>\n<li><strong>3 Units<\/strong><\/li>\n<\/ul>\n[\/mhc_tab][mhc_tab title=&#8221;\u0639\u062f\u062f \u0627\u0644\u0633\u0627\u0639\u0627\u062a \u0627\u0644\u0623\u0633\u0628\u0648\u0639\u064a\u0629&#8221;]\n<ul>\n<li><strong>2 hrs Theory<\/strong><\/li>\n<li><strong>2 hrs Laboratory<\/strong><\/li>\n<\/ul>\n[\/mhc_tab][mhc_tab title=&#8221;\u0646\u0648\u0639 \u0627\u0644\u0645\u0642\u0631\u0631&#8221;]\n<ul>\n<li><strong>Specialty<\/strong><\/li>\n<\/ul>\n[\/mhc_tab][mhc_tab title=&#8221;\u0627\u0644\u0623\u0633\u0628\u0642\u064a\u0629&#8221;]\n<ul>\n<li><strong>Pharmacology I, II <\/strong><\/li>\n<li><strong>Pharmaceutics<\/strong><\/li>\n<\/ul>\n[\/mhc_tab][mhc_tab title=&#8221;\u0648\u0635\u0641 \u0627\u0644\u0645\u0642\u0631\u0631&#8221;]\n<ul>\n<li>\n<p style=\"text-align: right;\"><strong>Course Description:\u00a0\u00a0 <\/strong><strong>(\u0648\u0635\u0641 \u0627\u0644\u0645\u0642\u0631\u0631)<\/strong><\/p>\n<p style=\"text-align: left;\"><strong>Brief Description:<\/strong><\/p>\n<p style=\"text-align: left;\">Teaching of the syllabus will be in accordance with current Libyan regulation and WHO proposals. This course will provide students with a fundamental understanding of the national and international legislation and law in pharmacy. activities of the pharmacist. Good Storage Practice. Classifications of hospitals, its function and pharmacy department. Drug information center. Large volume medications and principles of radio pharmaceutics and radiopharmaceuticals. As well as the use of nuclear radiation in the management of some disease.<\/p>\n<p style=\"text-align: left;\"><strong>Course Objectives:<\/strong><\/p>\n<p style=\"text-align: left;\">At the end of the course students will be able to: Explain local and international legalization in the field of pharmacy. Describe the organization structure of hospital and hospital pharmacy. Understand the manufacturing practice of various large volume medications. Understand the admixtures and incompatibilities of medications. Describe the management of inventory control in the hospital pharmacy. Classify the radioactive materials and understanding their clinical uses.<\/p>\n<p style=\"text-align: left;\"><strong>Generic Skills:<\/strong><\/p>\n<p style=\"text-align: left;\">The faculty is committed to ensuring that students have the full range of knowledge and skills required for full participation in all aspects of their lives, including skills enabling them to be life-long learners. To ensure graduates have this preparation, such generic skills as literacy and numeric, computer, interpersonal communications, and critical thinking skills will be embedded in all courses.<\/p>\n<p style=\"text-align: left;\"><strong>Attendance Expectations:<\/strong><\/p>\n<p style=\"text-align: left;\">Students are expected to attend every session of class, arriving on time, returning from breaks promptly and remaining until class is dismissed. Absences are permitted only for medical reasons and must be supported with a doctor\u2019s note.<\/p>\n<p style=\"text-align: left;\"><strong>\u00a0<\/strong><\/p>\n<p style=\"text-align: left;\"><strong>Content Breakdown:<\/strong><\/p>\n<table class=\" alignleft\" width=\"100%\">\n<tbody>\n<tr>\n<td width=\"27%\"><strong>Content Breakdown\\Week<\/strong><\/td>\n<td width=\"72%\"><strong>Topical Coverage<\/strong><\/td>\n<\/tr>\n<tr>\n<td width=\"27%\"><strong>Session 1 (Week 1)<\/strong><\/td>\n<td width=\"72%\"><strong>Unit I: Outlines of pharmacy legislation including Local regulations:<\/strong><\/td>\n<\/tr>\n<tr>\n<td width=\"27%\"><strong>Session 2 (Week 2)<\/strong><\/td>\n<td width=\"72%\">Outlines of pharmacy legislation including Local regulations.<\/td>\n<\/tr>\n<tr>\n<td width=\"27%\"><strong>Session 3 (Week 3)<\/strong><\/td>\n<td width=\"72%\"><strong>Unit II: Pharmacy as a system in health \u2013care delivery:<\/strong><\/p>\n<p>\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Introduction.<\/p>\n<p>\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 The scope of pharmacy &amp; activities of the pharmacist: The procedure for procurement &amp; warehousing of drugs and pharmaceuticals in the hospitals<\/td>\n<\/tr>\n<tr>\n<td width=\"27%\"><strong>Session 4 (Week 4)<\/strong><\/td>\n<td width=\"72%\">\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 The scope of pharmacy &amp; activities of the pharmacist: The responsibility of the hospital pharmacist.<\/p>\n<p>\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Different methods of drug distribution systems in hospitals.<\/p>\n<p>\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 The procedure for Distribution of Narcotic and other controlled substances<\/td>\n<\/tr>\n<tr>\n<td width=\"27%\"><strong>Session 5 (Week 5)<\/strong><\/td>\n<td width=\"72%\">\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 The scope of pharmacy &amp; activities of the pharmacist.<\/p>\n<p>\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Hospital pharmacist&#8217;s participation in continuing education programme.<\/p>\n<p>\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Inventory control, methods and types of inventory control.<\/td>\n<\/tr>\n<tr>\n<td width=\"27%\"><strong>Session 6 (Week 6)<\/strong><\/td>\n<td width=\"72%\">\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Pharmacy as a profession.<\/td>\n<\/tr>\n<tr>\n<td width=\"27%\"><strong>Session 7 (Week 7)<\/strong><\/td>\n<td width=\"72%\"><strong>Unit III: Storage of medical products:<\/strong><\/p>\n<p>\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Outlines of Good Storage Practice (GSP).<\/td>\n<\/tr>\n<tr>\n<td width=\"27%\"><strong>Session 8 (Week 8)<\/strong><\/td>\n<td width=\"72%\">\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Outlines of Good Storage Practice (GSP).<\/td>\n<\/tr>\n<tr>\n<td width=\"27%\"><strong>Session 9 (Week 9)<\/strong><\/td>\n<td width=\"72%\">\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Outlines of Good Storage Practice (GSP).<\/p>\n<p><strong>Unite IV: Hospital and it organization:<\/strong><\/p>\n<p>\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 The hospital and its requirements.<\/td>\n<\/tr>\n<tr>\n<td width=\"27%\"><strong>Session 10 (Week 10)<\/strong><\/td>\n<td width=\"72%\">\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Classifications of hospitals.<\/p>\n<p>\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Functions of hospitals.<\/p>\n<p>\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 The hospital pharmacy department.<\/td>\n<\/tr>\n<tr>\n<td width=\"27%\"><strong>Session 11 (Week 11)<\/strong><\/td>\n<td rowspan=\"4\" width=\"72%\"><strong>Midterm Assessment<\/strong><\/td>\n<\/tr>\n<tr>\n<td width=\"27%\"><strong>Session 12 (Week 12)<\/strong><\/td>\n<\/tr>\n<tr>\n<td width=\"27%\"><strong>Session 13 (Week 13)<\/strong><\/td>\n<\/tr>\n<tr>\n<td width=\"27%\"><strong>Session 14 (Week 14)<\/strong><\/td>\n<\/tr>\n<tr>\n<td width=\"27%\"><strong>Session 15 (Week 15)<\/strong><\/td>\n<td width=\"72%\">\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 The practices of hospital pharmacist in hospital.<\/td>\n<\/tr>\n<tr>\n<td width=\"27%\"><strong>Session 16 (Week 16)<\/strong><\/td>\n<td width=\"72%\">\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Location, facilities and personal.<\/p>\n<p>\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 The pharmacy and therapeutic committee.<\/td>\n<\/tr>\n<tr>\n<td width=\"27%\"><strong>Session 17 (Week 17)<\/strong><\/td>\n<td width=\"72%\"><strong>Unit VI: Drug information center (DIC):<\/strong><\/p>\n<p>\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Primary source of information.<\/p>\n<p>\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Secondary source of information.<\/p>\n<p>\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Tertiary source of information.<\/td>\n<\/tr>\n<tr>\n<td width=\"27%\"><strong>Session 18 (Week 18)<\/strong><\/td>\n<td width=\"72%\">\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Guidelines to establish (DIC) in hospitals.<\/p>\n<p>\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Services offered by DIC.<\/td>\n<\/tr>\n<tr>\n<td width=\"27%\"><strong>Session 19 (Week 19)<\/strong><\/td>\n<td width=\"72%\">\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Common faults in advising patients.<\/p>\n<p>\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 The hospital formulary.<\/td>\n<\/tr>\n<tr>\n<td width=\"27%\"><strong>Session 20 (Week 20)<\/strong><\/td>\n<td width=\"72%\"><strong>Unit VII: In-patient pharmacy service:<\/strong><\/p>\n<p>\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Fluid and electrolyte therapy.<\/td>\n<\/tr>\n<tr>\n<td width=\"27%\"><strong>Session 21 (Week 21)<\/strong><\/td>\n<td width=\"72%\">\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Fluid and electrolyte therapy.<\/td>\n<\/tr>\n<tr>\n<td width=\"27%\"><strong>Session 22(Week 22)<\/strong><\/td>\n<td width=\"72%\">\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Fluid and electrolyte therapy.<\/p>\n<p>\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Parenteral nutrition.<\/td>\n<\/tr>\n<tr>\n<td width=\"27%\"><strong>Session 23 (Week 23)<\/strong><\/td>\n<td width=\"72%\"><strong>Unit VIII: Parenteral admixtures and incompatibilities:<\/strong><\/td>\n<\/tr>\n<tr>\n<td width=\"27%\"><strong>Session 24 (Week 24)<\/strong><\/td>\n<td width=\"72%\"><strong>Unit IX: Methods of I.V administration and sets including flow rates, &amp; flow control:<\/strong><\/td>\n<\/tr>\n<tr>\n<td width=\"27%\"><strong>Session 25 (Week 25)<\/strong><\/td>\n<td width=\"72%\">\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Methods of I.V administration and sets including flow rates, &amp; flow control.<\/td>\n<\/tr>\n<tr>\n<td width=\"27%\"><strong>Session 26 (Week 26)<\/strong><\/td>\n<td width=\"72%\"><strong>Unit X: Radio pharmacy:<\/strong><\/p>\n<p>\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Introduction.<\/p>\n<p>\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 importance of radiopharmaceuticals, frequently used radio<\/p>\n<p>\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 pharmaceuticals in the hospital.<\/td>\n<\/tr>\n<tr>\n<td width=\"27%\"><strong>Session 27 (Week 27)<\/strong><\/td>\n<td width=\"72%\">\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Therapeutic and diagnostic radiopharmaceuticals in pharmacy<\/td>\n<\/tr>\n<tr>\n<td width=\"27%\"><strong>Session 28 (Week 28)<\/strong><\/td>\n<td width=\"72%\">\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 The method for handling radiopharmaceuticals in hospital.<\/p>\n<p>\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Radio-pharmaceutical quality control.<\/td>\n<\/tr>\n<tr>\n<td width=\"27%\"><strong>Practical work<\/strong><\/td>\n<td width=\"72%\">PracticalinHospitalPharmacy:<\/p>\n<p>\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Test for pyrogens on water for injection.<\/p>\n<p>\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Evaluation of the plastic transfusion bottles used for large volume parenterals.<\/p>\n<p>\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Operation of the sterilization equipment (Autoclave).<\/p>\n<p>\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Test for hydrolytic resistance of glass containers used for parenterals.<\/p>\n<p>\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Evaluation of prescription form.<\/p>\n<p>\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Preparation and sterilization of normal saline IP.<\/p>\n<p>\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Preparation and sterilization of dextrose injection IP.<\/p>\n<p>\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Study of drug profile of radiopharmaceuticals.<\/p>\n<p>\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Study of poisons information service.<\/p>\n<p>\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Study of drug information service.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p style=\"text-align: left;\"><strong>\u00a0<\/strong><\/p>\n<p style=\"text-align: left;\"><strong>Delivery:<\/strong><strong>\u00a0\u00a0\u00a0\u00a0\u00a0 <\/strong><\/p>\n<ul style=\"text-align: left;\">\n<li>Lectures (Tools: board, data show, video).<\/li>\n<li>Practical classes (Lab experiments+ preparation and sterilization of normal saline, evaluation of prescription form.<\/li>\n<\/ul>\n<p style=\"text-align: left;\"><strong>Course Assessments:<\/strong><\/p>\n<ul style=\"text-align: left;\">\n<li>20% Midyear exam<\/li>\n<li>10% Quizzes, reports, presentation<\/li>\n<li>10% Lab activities, exam<\/li>\n<li>20% Final Practical exam<\/li>\n<li>40% Final theoretical exam<\/li>\n<li>100% Total<\/li>\n<\/ul>\n<p style=\"text-align: left;\"><strong>\u00a0<\/strong><\/p>\n<p style=\"text-align: left;\"><strong>Textbooks:<\/strong><\/p>\n<ul style=\"text-align: left;\">\n<li>Modern dispensing and hospital pharmacy. N K Jain, G D Gupta 2018<\/li>\n<li>Hospital pharmacy sciences<\/li>\n<li>Aulton&#8217;s pharmaceutics<\/li>\n<li>Sciences direct website<\/li>\n<li>Additional Resources: Lectures Notes<\/li>\n<\/ul>\n<p style=\"text-align: left;\">\n<\/li>\n<\/ul>\n[\/mhc_tab] [\/mhc_tabs][\/mhc_column][\/mhc_row][mhc_row admin_label=&#8221;row&#8221;][mhc_column type=&#8221;4_4&#8243;][mhc_text admin_label=&#8221;\u0646\u0635 &#8211; Clinical Pharmacy (\u0635\u064a\u062f\u0644\u0629 \u0633\u0631\u064a\u0631\u064a\u0629)&#8221; background_layout=&#8221;light&#8221; text_orientation=&#8221;right&#8221; animation=&#8221;off&#8221;]\n<p><strong>Clinical Pharmacy (\u0635\u064a\u062f\u0644\u0629 \u0633\u0631\u064a\u0631\u064a\u0629)<br \/>\n\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640<\/strong><\/p>\n[\/mhc_text][mhc_tabs admin_label=&#8221;\u062a\u0628\u0648\u064a\u0628 &#8211; Clinical Pharmacy (\u0635\u064a\u062f\u0644\u0629 \u0633\u0631\u064a\u0631\u064a\u0629)&#8221; background_layout=&#8221;light&#8221; show_border=&#8221;on&#8221;] [mhc_tab title=&#8221;\u0631\u0645\u0632 \u0627\u0644\u0645\u0642\u0631\u0631&#8221;]\n<ul>\n<li>(PH402)<\/li>\n<\/ul>\n[\/mhc_tab][mhc_tab title=&#8221;\u0639\u062f\u062f \u0627\u0644\u0648\u062d\u062f\u0627\u062a&#8221;]\n<ul>\n<li><strong>4 Units<\/strong><\/li>\n<\/ul>\n[\/mhc_tab][mhc_tab title=&#8221;\u0639\u062f\u062f \u0627\u0644\u0633\u0627\u0639\u0627\u062a \u0627\u0644\u0623\u0633\u0628\u0648\u0639\u064a\u0629&#8221;]\n<ul>\n<li><strong>3 <\/strong><strong>hrs Theory<\/strong><\/li>\n<li><strong>2 hrs Practical<\/strong><\/li>\n<\/ul>\n[\/mhc_tab][mhc_tab title=&#8221;\u0646\u0648\u0639 \u0627\u0644\u0645\u0642\u0631\u0631&#8221;]\n<ul>\n<li><strong>General<\/strong><\/li>\n<\/ul>\n[\/mhc_tab][mhc_tab title=&#8221;\u0627\u0644\u0623\u0633\u0628\u0642\u064a\u0629&#8221;]\n<ul>\n<li><strong>Pharmacology I &amp; II<\/strong><\/li>\n<\/ul>\n[\/mhc_tab][mhc_tab title=&#8221;\u0648\u0635\u0641 \u0627\u0644\u0645\u0642\u0631\u0631&#8221;]\n<ul>\n<li>\n<p style=\"text-align: right;\"><strong>Course Description:\u00a0\u00a0 <\/strong><strong>(\u0648\u0635\u0641 \u0627\u0644\u0645\u0642\u0631\u0631)<\/strong><\/p>\n<p style=\"text-align: left;\"><strong>Brief Description:<\/strong><\/p>\n<p style=\"text-align: left;\">The common diseases covering etiology, clinical picture, diagnosis, investigations, and therapy.<\/p>\n<p style=\"text-align: left;\"><strong>Course Objectives:<\/strong><\/p>\n<p style=\"text-align: left;\">By the end of the course, students should be able to: Understanding the pathophysiology of selected disease states. Understanding the rationale for drug therapy and the management of a range of acute and chronic conditions. Identifies Drug Therapy Problems (DTPs). Makes Clinical Decisions through individualizing therapeutic plans. Skills in the critical evaluation of a range of health services literature.<\/p>\n<p style=\"text-align: left;\"><strong>Generic Skills:<\/strong><\/p>\n<p style=\"text-align: left;\">The faculty is committed to ensuring that students have the full range of knowledge and skills required for full participation in all aspects of their lives, including skills enabling them to be life-long learners. To ensure graduates have this preparation, such generic skills as literacy and numeric, computer, interpersonal communications, and critical thinking skills will be embedded in all courses.<\/p>\n<p style=\"text-align: left;\"><strong>Attendance Expectations:<\/strong><\/p>\n<p style=\"text-align: left;\">Students are expected to attend every session of class, arriving on time, returning from breaks promptly and remaining until class is dismissed. Absences are permitted only for medical reasons and must be supported with a doctor\u2019s note.<\/p>\n<p style=\"text-align: left;\"><strong>Routine activities of students during the clerkship<\/strong><\/p>\n<p style=\"text-align: left;\">1) Student will perform the following activities during clerkship rotations:<\/p>\n<ul style=\"text-align: left;\">\n<li>Taking history from the patient with special emphasis on medication history.<\/li>\n<li>Participation in Medical Rounds to learn how health care professionals.<\/li>\n<li>Assess\/ identify patient\u2019s disease and medication related problems<\/li>\n<li>Treat\/ resolve actual disease and medication related problems<\/li>\n<li>Prevent potential disease and medication related problem<\/li>\n<li>Learning medical terminologies commonly used by health care professionals in patient- care areas.<\/li>\n<li>Developing written and oral communication skills i.e. how to communicate effectively with health care professionals and others, both orally and in writing.<\/li>\n<li>Monitoring patient compliance statue &amp; adherence to drug therapy and to identify the factors responsible for non-compliance.<\/li>\n<li>Patient education and counseling to improve compliance during patient stay at the hospital and at the time of discharge.<\/li>\n<li>Reviewing patient medication therapy in the ward in order to learn how health care professionals diagnose\/ detect\/ identify &amp; manage the following medication related problems.<\/li>\n<li>Untreated conditions(s)<\/li>\n<li>Drug(s) without indication(s)<\/li>\n<li>Improper drug selection\/ taking wrong drug<\/li>\n<li>Sub therapeutic dose<\/li>\n<li>Excessive dose<\/li>\n<li>Improper duration<\/li>\n<li>Drug(s) not administered\/ Failure to receive medication<\/li>\n<li>Drug interactions<\/li>\n<li>Adverse drug reactions\/ intolerances<\/li>\n<li>Requiring dose adjustment in renal impairment.<\/li>\n<li>Requiring dose adjustment in hepatic impairment<\/li>\n<li>Therapeutic duplication<\/li>\n<li>Pregnancy\/ lactation related problem(s)<\/li>\n<li>Inappropriate dosage-form\/ route of administration<\/li>\n<li>Non-compliance<\/li>\n<li>Use of narrow therapeutic index drug(s) without monitoring<\/li>\n<li>Polypharmacy<\/li>\n<li>Cost related problems<\/li>\n<li>Miscellaneous medication related problems<\/li>\n<\/ul>\n<p style=\"text-align: left;\">2) Developing pharmaceutical care plan for the patient.<\/p>\n<p style=\"text-align: left;\">3) Learning how to provide Drug information to the patients and health care professionals.<\/p>\n<p style=\"text-align: left;\">4) Any other activity which the supervisor considers necessary to be performed by the students.<\/p>\n<p style=\"text-align: left;\"><strong>Content Breakdown:<\/strong><\/p>\n<table class=\" alignleft\" width=\"98%\">\n<tbody>\n<tr>\n<td width=\"27%\"><strong>Content Breakdown\\Week<\/strong><\/td>\n<td width=\"72%\"><strong>Topical Coverage<\/strong><\/td>\n<\/tr>\n<tr>\n<td width=\"27%\"><strong>Session 1 (Week 1)<\/strong><\/td>\n<td width=\"72%\"><strong>Introduction to the Patient Care Process:<\/strong><\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Definition of clinical pharmacy.<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Define and understand the role of the patient care process in providing care.<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Describe the components of comprehensive patient history taking.<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Apply a process to assess a patient for drug-related problems.<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Outline the components of patients\u2019 comprehensive care plans.<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Develop appropriate documentation of patient care.<\/td>\n<\/tr>\n<tr>\n<td width=\"27%\"><strong>Session 2 (Week 2)<\/strong><\/td>\n<td width=\"72%\"><strong>Principles of Patient Assessment:<\/strong><\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Describe the role of patient assessment in pharmacy practice.<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Describe the steps of symptoms assessment.<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Physical Assessment skills for Pharmacists<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 List available comprehensive guides to physical assessment.<\/td>\n<\/tr>\n<tr>\n<td width=\"27%\"><strong>Session 3 (Week 3)<\/strong><\/td>\n<td width=\"72%\"><strong>Critical Care Assessment:<\/strong><\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Describe the role of the pharmacist in the intensive care unit (ICU) and in the care of critically ill patients<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Describe the steps of critical care assessment, including collecting patient history, assessing the history of present illness, and conducting a review of systems Apply knowledge of routes of administration, intravenous compatibility, and pharmacokinetic.<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Changes in the critically ill to ensure effective and safe medication delivery to the patient.<\/td>\n<\/tr>\n<tr>\n<td width=\"27%\"><strong>Session 4 (Week 4)<\/strong><\/td>\n<td width=\"72%\"><strong>Drug interactions and adverse drug reactions<\/strong><\/td>\n<\/tr>\n<tr>\n<td width=\"27%\"><strong>Session 5 (Week 5)<\/strong><\/td>\n<td width=\"72%\"><strong>Clinical pharmacokinetics and therapeutic drug monitoring of selected drugs:<\/strong><\/p>\n<p>(Vancomycin, Aminoglycosides, digoxin, theophylline, carbamazepine)<\/td>\n<\/tr>\n<tr>\n<td width=\"27%\"><strong>Session 6 (Week 6)<\/strong><\/td>\n<td width=\"72%\"><strong>Drug therapy in special populations: Pregnancy, Lactation, Pediatric, Geriatric:<\/strong><\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Describe the goals of therapy and management strategy for menopause.<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Assess women for menopausal symptoms and who may be considering hormone therapy.<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Describe the goals of therapy and the therapeutic options for women seeking hormonal contraceptives.<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Assess women who are seeking combined hormonal contraception.<\/td>\n<\/tr>\n<tr>\n<td width=\"27%\"><strong>Session 7 (Week 7)<\/strong><\/td>\n<td width=\"72%\"><strong>Drug therapy in special populations: Pregnancy, Lactation, Pediatric, Geriatric:<\/strong><\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Recognize challenges related to patient assessment that are unique to pediatrics and neonatology.<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Describe the required components of a complete pharmacy assessment that are unique to pediatrics and neonatology.<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Gain a basic understanding of the differences in pediatric assessment as it relates to vital signs and common laboratory parameters<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Describe the process of comprehensive geriatric assessment.<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Identify the domains of comprehensive geriatric assessment.<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Describe practical tools that pharmacists cause in their assessment of older adults.<\/td>\n<\/tr>\n<tr>\n<td width=\"27%\"><strong>Session 8 (Week 8)<\/strong><\/td>\n<td width=\"72%\"><strong>Drug management of endocrine disorders:<\/strong><\/p>\n<p><strong>Diabetes Mellitus:<\/strong><\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Describe the diagnostic criteria and tests for diabetes.<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Describe glycemic control targets for different populations with diabetes.<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Describe treatment options for patients with diabetes.<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Apply various tests to assess glycemic control.<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Describe hypoglycemia, its symptoms and its treatment, and how to avoid it.<\/td>\n<\/tr>\n<tr>\n<td width=\"27%\"><strong>Session 9 (Week 9)<\/strong><\/td>\n<td width=\"72%\"><strong>Drug management of cardiovascular disorders:<\/strong><\/p>\n<p><strong>Dyslipidemia:<\/strong><\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Understanding the pathophysiology and it is classifications and Major Risk Factors<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Identify appropriate standards for the diagnosis of dyslipidemia and determine risk and prognosis for developing cardiovascular disease.<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Outline the management and treatment lines of hyperlipidemia<\/td>\n<\/tr>\n<tr>\n<td width=\"27%\"><strong>Session 10 (Week 10)<\/strong><\/td>\n<td width=\"72%\"><strong>Hypertension:<\/strong><\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Understanding approach of assessing a patient with hypertension.<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 To outline the various methods of diagnosis and monitoring for those with hypertension.<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 To outline appropriate follow-up and monitoring parameters for patients with hypertension.<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Complications of Hypertension<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 General Management of hypertension and Special patient groups<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Resistant hypertension, hypertensive urgencies, and emergencies<\/td>\n<\/tr>\n<tr>\n<td width=\"27%\"><strong>Session 11 (Week 11)<\/strong><\/td>\n<td rowspan=\"4\" width=\"72%\"><strong>Midterm Assessment<\/strong><\/td>\n<\/tr>\n<tr>\n<td width=\"27%\"><strong>Session 12 (Week 12)<\/strong><\/td>\n<\/tr>\n<tr>\n<td width=\"27%\"><strong>Session 13 (Week 13)<\/strong><\/td>\n<\/tr>\n<tr>\n<td width=\"27%\"><strong>Session 14 (Week 14)<\/strong><\/td>\n<\/tr>\n<tr>\n<td width=\"27%\"><strong>Session 15 (Week 15)<\/strong><\/td>\n<td width=\"72%\"><strong>Heart Failure:<\/strong><\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 To define heart failure (HF)<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 To review the diagnosis of HF including common signs and symptoms, risk factors and common diagnostic tests<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 To highlight goals of therapy in patients with HF<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 To outline a general approach to a patient with HF including initial assessment and ongoing evaluation and monitoring<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 To provide an approach to pharmacotherapy in HF including parameters for initiation and titration of therapy.<\/td>\n<\/tr>\n<tr>\n<td width=\"27%\"><strong>Session 16 (Week 16)<\/strong><\/td>\n<td width=\"72%\"><strong>Coronary heart disease:<\/strong><\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Pathophysiology of disease.<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Clinical presentation and diagnosis.<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Modifiable and non-modifiable Risk factors<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Clinical syndromes<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Medical management and prevention<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Evaluation of therapeutic outcomes.<\/td>\n<\/tr>\n<tr>\n<td width=\"27%\"><strong>Session 17 (Week 17)<\/strong><\/td>\n<td width=\"72%\"><strong>Thrombosis:<\/strong><\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 clinical manifestations of venous thromboembolism<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 pulmonary embolism<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 management of bleeding and excessive anticoagulation<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 general approach to the treatment<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 of venous thromboembolism. treatment of venous<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 thromboembolism in special populations.<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 clinical presentation and diagnosis of hit &amp; pharmacologic treatment options<\/td>\n<\/tr>\n<tr>\n<td width=\"27%\"><strong>Session 18 (Week 18)<\/strong><\/td>\n<td width=\"72%\"><strong>Stroke:<\/strong><\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Pathophysiology and classification<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Etiology and Risk factors.<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Clinical presentation (including diagnostic considerations.<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 General approach to treatment.<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 general information regarding safety and efficacy<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Use available parameters to measure and monitor target lipid goals for patients under treatment for dyslipidemia.\u00a0 Review recommendation of pivotal clinical trials).<\/td>\n<\/tr>\n<tr>\n<td width=\"27%\"><strong>Session 19 (Week 19)<\/strong><\/td>\n<td width=\"72%\"><strong>Drug management of respiratory disorders:<\/strong><\/p>\n<p><strong>Asthma:<\/strong><\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Describe the epidemiology, risk factors, clinical presentation, and diagnosis of asthma.<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Describe the goals of therapy and management strategies for asthma.<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Conduct an initial assessment of patients newly diagnosed with asthma.<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Describe the role of inhaled medications and optimal inhalation device use in asthma management.<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Conduct a follow-up assessment of patients with asthma.<\/td>\n<\/tr>\n<tr>\n<td width=\"27%\"><strong>Session 20 (Week 20)<\/strong><\/td>\n<td width=\"72%\"><strong>Chronic Obstructive Pulmonary Disease:<\/strong><\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Non-specific &amp; specific immunity.<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Cells involved in the immune response<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Types of immunoglobulin &amp; mechanism of antibody production.<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Hypersensitivity reactions.<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Serological tests.<\/td>\n<\/tr>\n<tr>\n<td width=\"27%\"><strong>Session 21 (Week 21)<\/strong><\/td>\n<td width=\"72%\"><strong>Drug management of neurological disorders:<\/strong><\/p>\n<p><strong>Epilepsy:<\/strong><\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Describe the epidemiology, etiology, risk factors, and pathophysiology of epilepsy.<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Describe the classification of different seizure types.<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Conduct initial assessment of patients newly diagnosed with epilepsy.<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Apply the general principles of antiepileptic drug therapy in the follow-up<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 assessment of patients with epilepsy.<\/td>\n<\/tr>\n<tr>\n<td width=\"27%\"><strong>Session 22 (Week 22)<\/strong><\/td>\n<td width=\"72%\"><strong>Drug management of psychiatric disorders:<\/strong><\/p>\n<p><strong>Depression:<\/strong><\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Describe the disease burden, epidemiology, diagnosis, prognosis, and management of major depressive disorder and other depressive disorders.<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Conduct initial assessment of patients who present with new diagnosis of depression or who are suspected of having depression but have not been formally diagnosed.<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Outline monitoring parameters and follow-up plans for patients using pharmacological therapy to manage their depression.<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Provide guidance to patients on how to manage partial\/non-response or adverse effects of medications.<\/td>\n<\/tr>\n<tr>\n<td width=\"27%\"><strong>Session 23 (Week 23)<\/strong><\/td>\n<td width=\"72%\"><strong>Drug management of bone and joint disorders:<\/strong><\/p>\n<p><strong>Osteoporosis:<\/strong><\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Assess fracture risk in patients using bone mineal density and risk factors.<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Identify potential complications from osteoporosis drug therapy.<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Assess appropriate monitoring parameters in osteoporosis including lab work and imaging.<\/p>\n<p><strong>Rheumatoid Arthritis:<\/strong><\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Describe the epidemiology, etiology, clinical presentation, and diagnosis of rheumatoid arthritis.<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Describe the goals of therapy and the management strategy for rheumatoid arthritis.<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Conduct an initial assessment of a patient newly diagnosed with rheumatoid arthritis.<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Conduct a follow-up assessment of a patient on disease-modifying ant<\/p>\n<p>rheumatic drug therapy, considering the regimen\u2019s effectiveness and safety and the patient\u2019s ability to adhere<\/td>\n<\/tr>\n<tr>\n<td width=\"27%\"><strong>Session 24 (Week 24)<\/strong><\/td>\n<td width=\"72%\"><strong>Drug management of infectious diseases:<\/strong><\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Describe the core elements of approach to infectious disease assessment.<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Describe the use of empiric, definitive, and prophylactic antimicrobial therapies.<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Describe the use of an antibiogram.<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Describe the approach to interpretation of culture results.<\/td>\n<\/tr>\n<tr>\n<td width=\"27%\"><strong>Session 25 (Week 25)<\/strong><\/td>\n<td width=\"72%\"><strong>CNS infection:<\/strong><\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Pathophysiology of CNS infections<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Most common pathogens &amp; risk factors<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Antibiotic selection issues<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Appropriate empirical antimicrobial regimens<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Prevention strategies<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Adjunctive therapy Components of monitoring plan<\/td>\n<\/tr>\n<tr>\n<td width=\"27%\"><strong>Session 26 (Week 26)<\/strong><\/td>\n<td width=\"72%\"><strong>Oncology:<\/strong><\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Pathophysiology, Type of cancer and risk factors<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Diagnosis and staging of tumor cancer<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Clinical presentation and Complications of Malignancy<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Oncology management. Combination chemotherapy, Adjuvant chemotherapy, Neoadjuvant chemotherapy.<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Complication of cancer chemotherapy.<\/td>\n<\/tr>\n<tr>\n<td width=\"27%\"><strong>Session 27 (Week 27)<\/strong><\/td>\n<td width=\"72%\"><strong>Leukemia and Lymphoma:<\/strong><\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Types and symptoms<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Risk factors and diagnostic methods,<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Management of therapy,<\/p>\n<p><strong>Chronic Non-cancer pain:<\/strong><\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 To identify key features of chronic non-cancer pain as a pathological form of pain<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 To review assessment strategies that allow the clinical pharmacist to assess pain and evidence of reduced coping in chronic pain Patients.<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 To link pain and coping assessments to pharmacotherapy optimization and management<\/td>\n<\/tr>\n<tr>\n<td width=\"27%\"><strong>Session 28 (Week 28)<\/strong><\/td>\n<td width=\"72%\"><strong>Drug management of anemia:<\/strong><\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Describe the classification of anemia.<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Complete a patient assessment and interpret laboratory findings to determine the most likely cause of anemia.<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Apply a monitoring and follow-up plan for patients initiated on treatment for anemia.<\/td>\n<\/tr>\n<tr>\n<td width=\"27%\"><strong>Practical Part:<\/strong><\/td>\n<td width=\"72%\"><strong>Clinical pharmacy Clerkship:<\/strong><\/p>\n<p>the fundamental goal of the clinical pharmacy clerkship is to provide a structured, practical and closely supervised professional experience that enables the students to better assume their future role as a competent clinical pharmacist. This goal includes the development of professional judgment, pharmaceutical care practice competencies and technical skills.<\/p>\n<p>At the completion of clerkship, the students should be able to demonstrate competencies in the following areas;<\/p>\n<p>1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 To obtain accurate medication histories &amp; gather other relevant patient\u2019s data.<\/p>\n<p>2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 To learn medical terminologies commonly used by health care professionals in the patient care areas.<\/p>\n<p>3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 To learn interpretation of common clinical laboratory tests.<\/p>\n<p>4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 To perform effective drug regimen reviews and identify actual and potential medication \u2013 related problems.<\/p>\n<p>5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 To develop a pharmaceutical care plan for the patient.<\/p>\n<p>6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 To recommend a therapeutic drug monitoring plan, including drug concentration monitoring and indicators of efficacy and toxicity.<\/p>\n<p>7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 To assess drug therapy regimen in a patient with alter renal or hepatic function.<\/p>\n<p>8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 To demonstrate an awareness of the assessment skills in areas necessary to monitor medication outcomes.<\/p>\n<p>9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Communicate effectively with health care professionals and others both orally and in<\/p>\n<p>10.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 To perform complete and accurate patient counseling and enhance patient education and compliance.<\/p>\n<p>11.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 To provide drug information to health care professionals and patients and to demonstrate competencies in the following areas:<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Indication \u2013 specific prescribing practice<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Appropriate drug dosage selection<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Appropriate dosage \u2013 form selection<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Drug use in pregnancy<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Drug use in pediatrics<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Drug use in geriatrics<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Dosage adjustment in renal impairment<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Dosage adjustment in hepatic impairment<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Management of drug interactions<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Detection &amp; management of adverse reaction &amp; drug induced diseases.<\/p>\n<p>12.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 To demonstrate professional attitude, motivation and ethics.<\/p>\n<p>13.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 To demonstrate the fundamental knowledge of pharmacotherapeutics in the areas necessary to provide the service.<\/p>\n<p>14.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 To provide the student opportunities to engage in scholarly activities (i.e, special projects, presentations, research activities).<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p style=\"text-align: left;\"><strong>\u00a0<\/strong><\/p>\n<p style=\"text-align: left;\"><strong>Delivery:<\/strong><strong>\u00a0\u00a0\u00a0\u00a0\u00a0 <\/strong><\/p>\n<p style=\"text-align: left;\">Lecture-based, Group interaction and discussion, medical clerkship \u2026..etc.<\/p>\n<p style=\"text-align: left;\"><strong>Course Assessments:<\/strong><\/p>\n<ul style=\"text-align: left;\">\n<li>20% Midyear Exam<\/li>\n<li>10% Quizzes, reports, presentation<\/li>\n<li>10% Practical exam<\/li>\n<li>20% FinalPractical<\/li>\n<li>40% FinalTheoreticalExam<\/li>\n<li>100% Total<\/li>\n<\/ul>\n<p style=\"text-align: left;\"><strong>\u00a0<\/strong><\/p>\n<p style=\"text-align: left;\"><strong>Textbooks:<\/strong><\/p>\n<ul>\n<li style=\"text-align: left;\">Patient Assessment in Clinical Pharmacy<\/li>\n<li style=\"text-align: left;\">Applied Therapeutics: The Clinical Use of Drugs. Marry Anne Koda-Kimble<\/li>\n<li style=\"text-align: left;\">Pharmacotherapy: A Pathophysiologic approach &#8211; Joseph T. Dipiro et al. Appleton &amp; Lange<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n[\/mhc_tab] [\/mhc_tabs][\/mhc_column][\/mhc_row][mhc_row admin_label=&#8221;row&#8221;][mhc_column type=&#8221;4_4&#8243;][mhc_text admin_label=&#8221;\u0646\u0635 &#8211; Pharmacy Practice (\u0645\u0645\u0627\u0631\u0633\u0629 \u0627\u0644\u0635\u064a\u062f\u0644\u0629)&#8221; background_layout=&#8221;light&#8221; text_orientation=&#8221;right&#8221; animation=&#8221;off&#8221;]\n<p><strong>Pharmacy Practice (\u0645\u0645\u0627\u0631\u0633\u0629 \u0627\u0644\u0635\u064a\u062f\u0644\u0629)<br \/>\n\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640\u0640<\/strong><\/p>\n[\/mhc_text][mhc_tabs admin_label=&#8221;\u062a\u0628\u0648\u064a\u0628 &#8211; Pharmacy Practice (\u0645\u0645\u0627\u0631\u0633\u0629 \u0627\u0644\u0635\u064a\u062f\u0644\u0629)&#8221; background_layout=&#8221;light&#8221; show_border=&#8221;on&#8221;] [mhc_tab title=&#8221;\u0631\u0645\u0632 \u0627\u0644\u0645\u0642\u0631\u0631&#8221;]\n<ul>\n<li>(PH407)<\/li>\n<\/ul>\n[\/mhc_tab][mhc_tab title=&#8221;\u0639\u062f\u062f \u0627\u0644\u0648\u062d\u062f\u0627\u062a&#8221;]\n<ul>\n<li><strong>3 Units<\/strong><\/li>\n<\/ul>\n[\/mhc_tab][mhc_tab title=&#8221;\u0639\u062f\u062f \u0627\u0644\u0633\u0627\u0639\u0627\u062a \u0627\u0644\u0623\u0633\u0628\u0648\u0639\u064a\u0629&#8221;]\n<ul>\n<li><strong>2 <\/strong><strong>hrs Theory<\/strong><\/li>\n<li><strong>2 hrs Practical<\/strong><\/li>\n<\/ul>\n[\/mhc_tab][mhc_tab title=&#8221;\u0646\u0648\u0639 \u0627\u0644\u0645\u0642\u0631\u0631&#8221;]\n<ul>\n<li><strong>Specialty<\/strong><\/li>\n<\/ul>\n[\/mhc_tab][mhc_tab title=&#8221;\u0627\u0644\u0623\u0633\u0628\u0642\u064a\u0629&#8221;]\n<ul>\n<li><strong>Pharmaceutics I, II <\/strong><\/li>\n<li><strong>Pharmacology I, II<\/strong><\/li>\n<\/ul>\n[\/mhc_tab][mhc_tab title=&#8221;\u0648\u0635\u0641 \u0627\u0644\u0645\u0642\u0631\u0631&#8221;]\n<ul>\n<li>\n<p style=\"text-align: right;\"><strong>Course Description:\u00a0\u00a0 <\/strong><strong>(\u0648\u0635\u0641 \u0627\u0644\u0645\u0642\u0631\u0631)<\/strong><\/p>\n<p style=\"text-align: left;\"><strong>Brief Description:<\/strong><\/p>\n<p style=\"text-align: left;\">The course provides the students with knowledge in pharmacy practice laws and therapeutic plan. Also provides the students with the knowledge about Patient&#8217;s factor&#8217;s in drug-product selection. Study the Responding to symptoms in pharmacy practice. The course provides the students with information in pharmacy system. In this course the students will be learning various skill such as dispensing of drugs, responding to minor ailments by providing suitable safe medication, patient counselling for improved patient care in the community set up.<\/p>\n<p style=\"text-align: left;\"><strong>Course Objectives:<\/strong><\/p>\n<p style=\"text-align: left;\">Upon completion of the course, the student shall be able to: Know various drug distribution methods in a hospital. Appreciate the pharmacy stores management and inventory control. Monitor drug therapy of patient through medication chart review and clinical review. Obtain medication history interview and counsel the patients. Identify drug related problems. Detect and assess adverse drug reactions. Interpret selected laboratory results (as monitoring parameters in therapeutics) of specific disease states. Know pharmaceutical care services. Do patient counseling in community pharmacy. Appreciate the concept of Rational drug therapy.<\/p>\n<p style=\"text-align: left;\"><strong>\u00a0<\/strong><\/p>\n<p style=\"text-align: left;\"><strong>Generic Skills:<\/strong><\/p>\n<p style=\"text-align: left;\">Independent learning, critical thinking, and problem solving. Basic IT and presentation skills. Integration of different fields of knowledge. Team working. Communication skills.<\/p>\n<p style=\"text-align: left;\"><strong>Attendance Expectations:<\/strong><\/p>\n<p style=\"text-align: left;\">Students are expected to attend every session of class, arriving on time, returning from breaks promptly and remaining until class is dismissed. Absences are permitted only for medical reasons and must be supported with a doctor\u2019s note.<\/p>\n<p style=\"text-align: left;\"><strong>Content Breakdown:<\/strong><\/p>\n<table class=\" alignleft\" width=\"100%\">\n<tbody>\n<tr>\n<td width=\"28%\"><strong>Content Breakdown\\Week<\/strong><\/td>\n<td width=\"71%\"><strong>Topical Coverage<\/strong><\/td>\n<\/tr>\n<tr>\n<td width=\"28%\"><strong>Session 1 (Week 1)<\/strong><\/td>\n<td width=\"71%\"><strong>Unit I: Pharmaceutical care:<\/strong><\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Introduction to Pharmaceutical care<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Pharmaceutical care and the scope of Pharmacy Practice<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Essential components of pharmaceutical care<\/p>\n<p><strong>Drug related problems:<\/strong><\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 The response of the profession of pharmacy to drug related problems.<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Exploration of the drug process.<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0 Clinical skills and Pharmacist&#8217;s role in pharmaceutical care.<\/td>\n<\/tr>\n<tr>\n<td width=\"28%\"><strong>Session 2 (Week 2)<\/strong><\/td>\n<td width=\"71%\"><strong>The development of the concept of pharmaceutical care:<\/strong><\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 The pharmacist&#8217;s functions.<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Functions related to the individual patient.<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Functions related to the community.<\/td>\n<\/tr>\n<tr>\n<td width=\"28%\"><strong>Session 3 (Week 3)<\/strong><\/td>\n<td width=\"71%\">\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 The Pharmacist&#8217;s Working up of Drug Therapy (The PWDT process)<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0 Data collection (Patient data, patient past medical history, patient family history, patient social history, patient history of present illness, physical finding, laboratory and test results.<\/td>\n<\/tr>\n<tr>\n<td width=\"28%\"><strong>Session 4 (Week 4)<\/strong><\/td>\n<td width=\"71%\">\u2022\u00a0\u00a0\u00a0\u00a0 Clinical Skills and Pharmacist\u2019s role in pharmaceutical care<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0 Pharmaceutical car as the model of Pharmacy Practice<\/td>\n<\/tr>\n<tr>\n<td width=\"28%\"><strong>Session 5 (Week 5)<\/strong><\/td>\n<td width=\"71%\"><strong>Unit II: Therapeutic Plan<\/strong><\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 The CORE pharmacotherapy plan<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 The CORE pharmacotherapy problems.<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 The FARM progress note<\/td>\n<\/tr>\n<tr>\n<td width=\"28%\"><strong>Session 6 (Week 6)<\/strong><\/td>\n<td width=\"71%\"><strong>Patient&#8217;s factors in drug-product selection:<\/strong><\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 The pharmacist&#8217;s responsibility and role in drug product selection<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Factors affecting drug-product selection<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Patient acceptance consideration.<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Patient age consideration<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Environmental consideration<\/td>\n<\/tr>\n<tr>\n<td width=\"28%\"><strong>Session 7 (Week 7)<\/strong><\/td>\n<td width=\"71%\">\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Disease state consideration<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Patient compliance<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0 Biopharmaceutical consideration<\/td>\n<\/tr>\n<tr>\n<td width=\"28%\"><strong>Session 8 (Week 8)<\/strong><\/td>\n<td width=\"71%\"><strong>Performance of drugs in clinical practice and factories effects their methods of presentation:<\/strong><\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Concept of optimized drug products and controlled release delivery systems (CR-DDS)<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Definitions<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Optimized controlled release (CR) products<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Advantages of sustained \/controlled drug therapy<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Categories of non-immediate delivery systems<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Types of CR-DDS (examples)<\/td>\n<\/tr>\n<tr>\n<td width=\"28%\"><strong>Session 9 (Week 9)<\/strong><\/td>\n<td width=\"71%\"><strong>Unit III: Drug supply<\/strong><\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 The goal of drug supply<\/p>\n<p>\u2022\u00a0\u00a0\u00a0 The drug supply process<\/td>\n<\/tr>\n<tr>\n<td width=\"28%\"><strong>Session 10 (Week 10)<\/strong><\/td>\n<td width=\"71%\">\u2022\u00a0\u00a0\u00a0\u00a0 Problems in the drug supply process<\/td>\n<\/tr>\n<tr>\n<td width=\"28%\"><strong>Session 11 (Week 11)<\/strong><\/td>\n<td rowspan=\"4\" width=\"71%\"><strong>Midterm Assessment<\/strong><\/td>\n<\/tr>\n<tr>\n<td width=\"28%\"><strong>Session 12 (Week 12)<\/strong><\/td>\n<\/tr>\n<tr>\n<td width=\"28%\"><strong>Session 13 (Week 13)<\/strong><\/td>\n<\/tr>\n<tr>\n<td width=\"28%\"><strong>Session 14 (Week 14)<\/strong><\/td>\n<\/tr>\n<tr>\n<td width=\"28%\"><strong>Session 15 (Week 15)<\/strong><\/td>\n<td width=\"71%\">\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Improving drug supply<\/p>\n<p>\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 The dimensions of drug supply<\/td>\n<\/tr>\n<tr>\n<td width=\"28%\"><strong>Session 16 (Week 16)<\/strong><\/td>\n<td width=\"71%\"><strong>Unit IV: Responding to symptoms in pharmacy practice through OTC and counseling:<\/strong><\/p>\n<p><strong>Responding to symptoms in Pharmacy Practice:<\/strong><\/p>\n<p><strong>The Communication Process\u201d<\/strong><\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 The goal of effective communications<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 The scope of medication-counseling sessions: (In organized health care setting, In the community setting).<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Patient assessment and consultation self-medication: (Importance of communication skills, Provision of pharmaceutical care through Patient-Pharmacist communication process).<\/td>\n<\/tr>\n<tr>\n<td width=\"28%\"><strong>Session 17 (Week 17)<\/strong><\/td>\n<td width=\"71%\"><strong>Non-Prescription medications (OTC medications):<\/strong><\/p>\n<p><strong>OTC criteria according to international stranded<\/strong><\/p>\n<p><strong>Label requirements for non-prescription medicine<\/strong><\/p>\n<p><strong>Non-prescription medication as a primary therapy and related conditions: <\/strong><\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Antidiarrheal and other gastrointestinal products<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Laxative products<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Antacids and other gastrointestinal reflux disease products).<\/td>\n<\/tr>\n<tr>\n<td width=\"28%\"><strong>Session 18 (Week 18)<\/strong><\/td>\n<td width=\"71%\">\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Cold and Allergy product<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Internal analgesics (management of headache, pain and fever)<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Menstrual products<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Acne Products<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Others<\/td>\n<\/tr>\n<tr>\n<td width=\"28%\"><strong>Session 19 (Week 19)<\/strong><\/td>\n<td width=\"71%\"><strong>In-Home testing and monitoring devices:<\/strong><\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Diabetes care products and monitoring kits<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Pregnancy testing and ovulation prediction testing kits<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Fecal occult blood kits<\/td>\n<\/tr>\n<tr>\n<td width=\"28%\"><strong>Session 20 (Week 20)<\/strong><\/td>\n<td width=\"71%\">\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Cholesterol monitoring kit<\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Home blood pressure and temperature monitoring<\/td>\n<\/tr>\n<tr>\n<td width=\"28%\"><strong>Session 21 (Week 21)<\/strong><\/td>\n<td width=\"71%\"><strong>Unit V: Dispensing prescriptions:<\/strong><\/td>\n<\/tr>\n<tr>\n<td width=\"28%\"><strong>Session 22 (Week 22)<\/strong><\/td>\n<td width=\"71%\"><strong>Unit VI: Mathematical principles of drug therapy:<\/strong><\/td>\n<\/tr>\n<tr>\n<td width=\"28%\"><strong>Session 23 (Week 23)<\/strong><\/td>\n<td width=\"71%\"><strong>Unit VII: Pharmacy system:<\/strong><\/td>\n<\/tr>\n<tr>\n<td width=\"28%\"><strong>Session 24 (Week 24)<\/strong><\/td>\n<td width=\"71%\">Pharmacy system<\/td>\n<\/tr>\n<tr>\n<td width=\"28%\"><strong>Session 25 (Week 25)<\/strong><\/td>\n<td width=\"71%\"><strong>Pharmacy and therapeutic committee<\/strong><\/p>\n<p>\u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Organization, functions, Policies of the pharmacy and therapeutic committee in including drugs into formulary, inpatient and outpatient prescription, automatic stop order, and emergency drug list preparation.<\/td>\n<\/tr>\n<tr>\n<td width=\"28%\"><strong>Session 26 (Week 26)<\/strong><\/td>\n<td width=\"71%\"><strong>Unit VIII: Pharmacy information and research:<\/strong><\/td>\n<\/tr>\n<tr>\n<td width=\"28%\"><strong>Session 27 (Week 27)<\/strong><\/td>\n<td width=\"71%\">Pharmacy information and research<\/td>\n<\/tr>\n<tr>\n<td width=\"28%\"><strong>Session 28 (Week 28)<\/strong><\/td>\n<td width=\"71%\">Pharmacy information and research<\/td>\n<\/tr>\n<tr>\n<td width=\"28%\"><strong>Practical Work<\/strong><\/td>\n<td width=\"71%\">N.B. Practical sessions are illustrating the theoretical concepts of the above<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p style=\"text-align: left;\"><strong>\u00a0<\/strong><\/p>\n<p style=\"text-align: left;\"><strong>Delivery:<\/strong><strong>\u00a0\u00a0\u00a0\u00a0\u00a0 <\/strong><\/p>\n<ul style=\"text-align: left;\">\n<li>Lecture-based, Group interaction and discussion, medical clerkship \u2026.. etc.<\/li>\n<\/ul>\n<p style=\"text-align: left;\"><strong>Course Assessments:<\/strong><\/p>\n<ul style=\"text-align: left;\">\n<li>20% Midyear Examination<\/li>\n<li>10% Practical continuous Assessment<\/li>\n<li>10% Quizzes, reports, presentation<\/li>\n<li>20% Final practical Examination<\/li>\n<li>40% Final written Examination<\/li>\n<li>Total 100%<\/li>\n<\/ul>\n<p style=\"text-align: left;\"><strong>\u00a0<\/strong><\/p>\n<p style=\"text-align: left;\"><strong>Textbooks:<\/strong><\/p>\n<ul style=\"text-align: left;\">\n<li>Parthasarathi G, Karin Nyfort-Hansen, Milap C Nahata. A textbook of Clinical Pharmacy Practice- essential concepts and skills, 1<sup>st<\/sup> \u00a0\u00a0\u00a0 Chennai: Orient Longman Private Limited; 2004.<\/li>\n<li>William E. Hassan. Hospital pharmacy, 5th ed. Philadelphia: Lea &amp; Febiger;1986.<\/li>\n<li>Tipnis Bajaj. Hospital Pharmacy, 1st ed. Maharashtra: Career Publications; 2008.<\/li>\n<li>Scott LT. Basic skills in interpreting laboratory data, 4thed. American Society of Health System Pharmacists Inc.; 2009.<\/li>\n<li>Parmar N.S. Health Education and Community Pharmacy, 18th ed. India: CBS Publishers &amp; Distributers; 2008.<\/li>\n<\/ul>\n<p style=\"text-align: left;\"><strong>Journals:<\/strong><\/p>\n<ul style=\"text-align: left;\">\n<li>Therapeutic drug monitoring. ISSN: 0163-4356<\/li>\n<li>Journal of pharmacy practice. ISSN: 0974-8326<\/li>\n<li>American journal of health system pharmacy. ISSN: 1535-2900 (online)<\/li>\n<li>Pharmacy times (Monthly magazine)<\/li>\n<\/ul>\n<p style=\"text-align: left;\">\n<\/li>\n<\/ul>\n[\/mhc_tab] [\/mhc_tabs][\/mhc_column][\/mhc_row][\/mhc_section][mhc_section shared_module=&#8221;1862&#8243; admin_label=&#8221;\u0642\u0633\u0645&#8221; fullwidth=&#8221;off&#8221; specialty=&#8221;off&#8221; transparent_background=&#8221;on&#8221; gradient_background=&#8221;off&#8221; background_color=&#8221;#0b0b21&#8243; gradient_style=&#8221;diagonal_bottom&#8221; inner_shadow=&#8221;on&#8221; parallax=&#8221;on&#8221; parallax_method=&#8221;off&#8221; video_pause=&#8221;off&#8221; allow_advanced_padding=&#8221;on&#8221; remove_padding=&#8221;on&#8221; force_fullwidth=&#8221;off&#8221; column_paddings=&#8221;padding-0pct&#8221; column_match_heights=&#8221;off&#8221; separator_top=&#8221;off&#8221; separator_bottom=&#8221;off&#8221; background_color_second=&#8221;#667451&#8243; transparent_image=&#8221;17&#8243; disabled=&#8221;off&#8221; background_image=&#8221;https:\/\/asmarya.edu.ly\/pharmacy\/wp-content\/uploads\/2024\/03\/IMG-Footer.png&#8221; video_hide=&#8221;off&#8221; background_leak=&#8221;off&#8221; background_leak_color=&#8221;#ffffff&#8221; background_leak_size=&#8221;50&#8243; background_image_size=&#8221;cover&#8221; background_image_repeat=&#8221;no-repeat&#8221; background_image_position_x=&#8221;center&#8221; background_image_position_y=&#8221;center&#8221; animation=&#8221;off&#8221; animation_color=&#8221;#ffffff&#8221; mobile_2_pr_row=&#8221;off&#8221; mobile_reverse=&#8221;off&#8221;][mhc_row admin_label=&#8221;\u0635\u0641&#8221;][mhc_column type=&#8221;4_4&#8243;][mhc_divider admin_label=&#8221;\u0641\u0627\u0635\u0644&#8221; show_divider=&#8221;off&#8221; color=&#8221;#44cdcd&#8221; borderw=&#8221;1&#8243; custom_orientation=&#8221;right&#8221; height=&#8221;15&#8243; divider_style=&#8221;solid&#8221; keep_visible=&#8221;off&#8221; custom_radius=&#8221;on&#8221;]\n<p>&nbsp;<\/p>\n[\/mhc_divider][\/mhc_column][mhc_column type=&#8221;4_4&#8243;][\/mhc_column][\/mhc_row][mhc_row admin_label=&#8221;\u0635\u0641&#8221;][mhc_column type=&#8221;1_3&#8243;][mhc_blurb admin_label=&#8221;\u0627\u0644\u0628\u0631\u064a\u062f \u0627\u0644\u0623\u0644\u0643\u062a\u0631\u0648\u0646\u064a&#8221; title=&#8221;\u0627\u0644\u0628\u0631\u064a\u062f \u0627\u0644\u0625\u0644\u0643\u062a\u0631\u0648\u0646\u064a&#8221; url_new_window=&#8221;off&#8221; use_icon=&#8221;on&#8221; font_list=&#8221;mhicons&#8221; font_mhicons=&#8221;%%383%%&#8221; icon_color=&#8221;#ffffff&#8221; use_circle=&#8221;off&#8221; use_circle_bg=&#8221;off&#8221; circle_color=&#8221;#44cdcd&#8221; use_circle_border=&#8221;off&#8221; circle_border_color=&#8221;#44cdcd&#8221; icon_placement=&#8221;right&#8221; animation=&#8221;right&#8221; background_layout=&#8221;dark&#8221; text_orientation=&#8221;right&#8221; use_background=&#8221;off&#8221; background_color=&#8221;#f5f5f5&#8243; wrap_inside_link=&#8221;off&#8221; hoverfx=&#8221;none&#8221; use_icon_size=&#8221;off&#8221; icon_size=&#8221;50&#8243; circle_radius=&#8221;100&#8243;]\n<p>info@ph.asmarya.edu.ly<\/p>\n[\/mhc_blurb][\/mhc_column][mhc_column type=&#8221;1_3&#8243;][mhc_blurb admin_label=&#8221;\u0631\u0642\u0645 \u0627\u0644\u0647\u0627\u062a\u0641&#8221; title=&#8221;\u0631\u0642\u0645 \u0627\u0644\u0647\u0627\u062a\u0641&#8221; url_new_window=&#8221;off&#8221; use_icon=&#8221;on&#8221; font_list=&#8221;mhicons&#8221; font_mhicons=&#8221;%%424%%&#8221; icon_color=&#8221;#ffffff&#8221; use_circle=&#8221;off&#8221; use_circle_bg=&#8221;off&#8221; circle_color=&#8221;#44cdcd&#8221; use_circle_border=&#8221;off&#8221; circle_border_color=&#8221;#44cdcd&#8221; icon_placement=&#8221;right&#8221; animation=&#8221;right&#8221; background_layout=&#8221;dark&#8221; text_orientation=&#8221;right&#8221; use_background=&#8221;off&#8221; background_color=&#8221;#f5f5f5&#8243; wrap_inside_link=&#8221;off&#8221; hoverfx=&#8221;none&#8221; use_icon_size=&#8221;off&#8221; icon_size=&#8221;50&#8243; circle_radius=&#8221;100&#8243;]\n<p>00000000<\/p>\n[\/mhc_blurb][\/mhc_column][mhc_column type=&#8221;1_3&#8243;][mhc_blurb admin_label=&#8221;\u0645\u0628\u0646\u0649 \u0627\u0644\u0625\u062f\u0627\u0631\u0629 \u0627\u0644\u0639\u0627\u0645\u0629 \u0644\u0644\u062c\u0627\u0645\u0639\u0629&#8221; title=&#8221;\u0627\u0644\u0639\u0646\u0648\u0627\u0646&#8221; url_new_window=&#8221;off&#8221; use_icon=&#8221;on&#8221; font_list=&#8221;mhicons&#8221; font_mhicons=&#8221;%%394%%&#8221; icon_color=&#8221;#ffffff&#8221; use_circle=&#8221;off&#8221; use_circle_bg=&#8221;off&#8221; circle_color=&#8221;#44cdcd&#8221; use_circle_border=&#8221;off&#8221; circle_border_color=&#8221;#44cdcd&#8221; icon_placement=&#8221;right&#8221; animation=&#8221;right&#8221; background_layout=&#8221;dark&#8221; text_orientation=&#8221;right&#8221; use_background=&#8221;off&#8221; background_color=&#8221;#f5f5f5&#8243; wrap_inside_link=&#8221;off&#8221; hoverfx=&#8221;none&#8221; use_icon_size=&#8221;off&#8221; icon_size=&#8221;50&#8243; circle_radius=&#8221;100&#8243;]\n<p>\u0645\u0628\u0646\u0649 \u0627\u0644\u0625\u062f\u0627\u0631\u0629 \u0627\u0644\u0639\u0627\u0645\u0629 \u0644\u0644\u062c\u0627\u0645\u0639\u0629<\/p>\n<p>\u0627\u0644\u0642\u0627\u0637\u0639 -\u0628<\/p>\n<p>\u0632\u0644\u064a\u062a\u0646 \u0644\u064a\u0628\u064a\u0627<\/p>\n[\/mhc_blurb][\/mhc_column][\/mhc_row][mhc_row admin_label=&#8221;\u0635\u0641&#8221;][mhc_column type=&#8221;4_4&#8243;][mhc_divider admin_label=&#8221;\u0641\u0627\u0635\u0644&#8221; show_divider=&#8221;on&#8221; color=&#8221;#5791c1&#8243; borderw=&#8221;1&#8243; custom_orientation=&#8221;center&#8221; divider_style=&#8221;solid&#8221; keep_visible=&#8221;off&#8221; custom_radius=&#8221;on&#8221; height=&#8221;10&#8243; animation=&#8221;off&#8221;]\n<p>&nbsp;<\/p>\n[\/mhc_divider][\/mhc_column][\/mhc_row][mhc_row admin_label=&#8221;\u0635\u0641&#8221;][mhc_column type=&#8221;1_4&#8243;][mhc_text admin_label=&#8221;\u0639\u062f\u062f \u0627\u0644\u0632\u0648\u0627\u0631&#8221; background_layout=&#8221;dark&#8221; text_orientation=&#8221;right&#8221; animation=&#8221;off&#8221;]     <div id=\"visitor-counter\" style=\"position: relative; width: 100%; height: 500px;\">\r\n        <div style=\"position: absolute; top: 10px; left: 50%; transform: translateX(-50%); color: white; background: rgba(0, 0, 0, 0.5); padding: 10px 20px; border-radius: 10px; z-index: 10;\">\r\n            \u0639\u062f\u062f \u0627\u0644\u0632\u0648\u0627\u0631: 170,867        <\/div>\r\n        <canvas id=\"globe-canvas\"><\/canvas>\r\n    <\/div>\r\n    <script src=\"https:\/\/cdnjs.cloudflare.com\/ajax\/libs\/three.js\/r134\/three.min.js\"><\/script>\r\n    <script>\r\n        const container = document.getElementById('visitor-counter').parentNode;\r\n        const canvas = document.getElementById('globe-canvas');\r\n        const renderer = new THREE.WebGLRenderer({ canvas, alpha: true });\r\n        renderer.setSize(container.offsetWidth, container.offsetHeight);\r\n\r\n        const scene = new THREE.Scene();\r\n        const camera = new THREE.PerspectiveCamera(75, container.offsetWidth \/ container.offsetHeight, 0.1, 1000);\r\n        camera.position.z = 15;\r\n\r\n        const geometry = new THREE.SphereGeometry(5, 64, 64);\r\n        const texture = new THREE.TextureLoader().load('https:\/\/asmarya.edu.ly\/ar\/wp-content\/uploads\/2024\/11\/map-image.jpg'); \/\/ \u0627\u0633\u062a\u0628\u062f\u0644 \u0627\u0644\u0631\u0627\u0628\u0637 \u0628\u062e\u0631\u064a\u0637\u0629 \u0627\u0644\u0639\u0627\u0644\u0645\r\n        const material = new THREE.MeshStandardMaterial({ map: texture });\r\n        const globe = new THREE.Mesh(geometry, material);\r\n        scene.add(globe);\r\n\r\n        const light = new THREE.PointLight(0xffffff, 1);\r\n        light.position.set(10, 10, 10);\r\n        scene.add(light);\r\n\r\n        const ambientLight = new THREE.AmbientLight(0x404040, 0.5);\r\n        scene.add(ambientLight);\r\n\r\n        function animate() {\r\n            requestAnimationFrame(animate);\r\n            globe.rotation.y += 0.01;\r\n            renderer.render(scene, camera);\r\n        }\r\n        animate();\r\n\r\n        \/\/ \u062a\u062d\u062f\u064a\u062b \u0627\u0644\u062d\u062c\u0645 \u0639\u0646\u062f \u062a\u063a\u064a\u064a\u0631 \u0646\u0627\u0641\u0630\u0629 \u0627\u0644\u0645\u062a\u0635\u0641\u062d\r\n        window.addEventListener('resize', () => {\r\n            renderer.setSize(container.offsetWidth, container.offsetHeight);\r\n            camera.aspect = container.offsetWidth \/ container.offsetHeight;\r\n            camera.updateProjectionMatrix();\r\n        });\r\n    <\/script>\r\n     [\/mhc_text][mhc_text admin_label=&#8221;\u0639\u062f\u062f \u0627\u0644\u0632\u0648\u0627\u0631&#8221; background_layout=&#8221;dark&#8221; text_orientation=&#8221;right&#8221; animation=&#8221;off&#8221; disabled=&#8221;on&#8221;] <script type=\"text\/javascript\" src=\"\/\/rf.revolvermaps.com\/0\/0\/8.js?i=5nl4zbfhmwg&amp;m=0&amp;c=ff0000&amp;cr1=ffffff&amp;f=arial&amp;l=33\" async=\"async\"><\/script> [\/mhc_text][\/mhc_column][mhc_column type=&#8221;1_4&#8243;][mhc_text admin_label=&#8221;\u0631\u0648\u0627\u0628\u0637 \u0633\u0631\u064a\u0639\u0629&#8221; background_layout=&#8221;dark&#8221; text_orientation=&#8221;right&#8221; animation=&#8221;off&#8221;]\n<p><strong>\u0631\u0648\u0627\u0628\u0637 \u0633\u0631\u064a\u0639\u0629<\/strong><\/p>\n<hr \/>\n<p><span style=\"color: #ffffff; font-size: 14px;\"><a style=\"color: #ffffff;\" href=\"http:\/\/www.asmarya.edu.ly\/ar\/\">\u0645\u0648\u0642\u0639 \u0627\u0644\u062c\u0627\u0645\u0639\u0629\u00a0<\/a><\/span><br \/>\n<span style=\"color: #ffffff; font-size: 14px;\"><a style=\"color: #ffffff;\" href=\"https:\/\/sms.asmarya.edu.ly\/zlpharm\/login_ing.php\">\u0627\u0644\u0628\u0648\u0627\u0628\u0629 \u0627\u0644\u0625\u0644\u0643\u062a\u0631\u0648\u0646\u064a\u0629\u00a0<\/a><\/span><br \/>\n<span style=\"color: #ffffff; font-size: 14px;\"><a style=\"color: #ffffff;\" href=\"https:\/\/asmarya.edu.ly\/ar\/?page_id=1207\">\u0627\u0644\u0645\u0643\u062a\u0628\u0627\u062a \u0648\u0627\u0644\u0645\u0637\u0628\u0648\u0639\u0627\u062a\u00a0<\/a><\/span><br \/>\n<span style=\"color: #ffffff; font-size: 14px;\"><a style=\"color: #ffffff;\" href=\"https:\/\/asmarya.edu.ly\/ar\/?page_id=444\">\u0627\u0644\u0645\u062c\u0644\u0627\u062a \u0627\u0644\u0639\u0644\u0645\u064a\u0629\u00a0<\/a><\/span><br \/>\n<span style=\"color: #ffffff; font-size: 14px;\"><a style=\"color: #ffffff;\" href=\"http:\/\/dspace.asmarya.edu.ly\/\">\u0627\u0644\u0645\u0633\u062a\u0648\u062f\u0639 \u0627\u0644\u0631\u0642\u0645\u064a<\/a><\/span><\/p>\n[\/mhc_text][\/mhc_column][mhc_column type=&#8221;1_4&#8243;][mhc_text admin_label=&#8221;\u0631\u0648\u0627\u0628\u0637 \u062e\u0627\u0631\u062c\u064a\u0629&#8221; background_layout=&#8221;dark&#8221; text_orientation=&#8221;right&#8221; animation=&#8221;off&#8221;]\n<p><strong>\u0631\u0648\u0627\u0628\u0637 \u062e\u0627\u0631\u062c\u064a\u0629<\/strong><\/p>\n<hr \/>\n<p><span style=\"color: #ffffff;\"><a style=\"color: #ffffff;\" href=\"https:\/\/mhesr.gov.ly\/\">\u0648\u0632\u0627\u0631\u0629 \u0627\u0644\u062a\u0639\u0644\u064a\u0645 \u0627\u0644\u0639\u0627\u0644\u064a \u0648\u0627\u0644\u0628\u062d\u062b \u0627\u0644\u0639\u0644\u0645\u064a<\/a>\u00a0<\/span><br \/>\n<span style=\"color: #ffffff;\"><a style=\"color: #ffffff;\" href=\"https:\/\/lsjp.epc.ly\/ar\">\u0645\u0646\u0635\u0629 \u0627\u0644\u0645\u062c\u0644\u0627\u062a \u0627\u0644\u0644\u064a\u0628\u064a\u0629 \u0627\u0644\u0645\u062d\u0643\u0645\u0629<\/a><\/span><br \/>\n<span style=\"color: #ffffff;\"><a style=\"color: #ffffff;\" href=\"https:\/\/qaa.ly\/\">\u0627\u0644\u0645\u0631\u0643\u0632 \u0627\u0644\u0648\u0637\u0646\u064a \u0644\u0636\u0645\u0627\u0646 \u0627\u0644\u062c\u0648\u062f\u0629 \u0648\u0627\u0639\u062a\u0645\u0627\u062f \u0627\u0644\u0645\u0624\u0633\u0633\u0627\u062a \u0627\u0644\u062a\u0639\u0644\u064a\u0645\u064a\u0629 \u0648\u0627\u0644\u062a\u062f\u0631\u064a\u0628\u064a\u0629\u00a0<\/a>\u00a0<\/span><br \/>\n<span style=\"color: #ffffff;\"><a style=\"color: #ffffff;\" href=\"https:\/\/lsjp.epc.ly\/public\/ar\">\u0627\u0644\u0647\u064a\u0626\u0629 \u0627\u0644\u0648\u0637\u0646\u064a\u0629 \u0644\u0644\u0628\u062d\u062b \u0627\u0644\u0639\u0644\u0645\u064a<\/a>\u00a0<\/span><br \/>\n<span style=\"color: #ffffff;\"><a style=\"color: #ffffff;\" href=\"https:\/\/uot.edu.ly\/\">\u062c\u0627\u0645\u0639\u0629 \u0637\u0631\u0627\u0628\u0644\u0633<\/a><\/span><br \/>\n<span style=\"color: #ffffff;\"><a style=\"color: #ffffff;\" href=\"https:\/\/uob.edu.ly\/ar\/\">\u062c\u0627\u0645\u0639\u0629 \u0628\u0646\u063a\u0627\u0632\u064a\u00a0<\/a><\/span><br \/>\n<span style=\"color: #ffffff;\"><a style=\"color: #ffffff;\" href=\"https:\/\/www.misuratau.edu.ly\/\">\u062c\u0627\u0645\u0639\u0629 \u0645\u0635\u0631\u0627\u062a\u0629\u00a0<\/a><\/span><br \/>\n<span style=\"color: #ffffff;\"><a style=\"color: #ffffff;\" href=\"https:\/\/elmergib.edu.ly\/\">\u062c\u0627\u0645\u0639\u0629 \u0627\u0644\u0645\u0631\u0642\u0628\u00a0<\/a><\/span><\/p>\n[\/mhc_text][\/mhc_column][mhc_column type=&#8221;1_4&#8243;][mhc_text admin_label=&#8221;\u0627\u062a\u0635\u0644 \u0628\u0646\u0627 &#8221; background_layout=&#8221;dark&#8221; text_orientation=&#8221;right&#8221; animation=&#8221;off&#8221;]\n<p><strong>\u0623\u0648\u0642\u0627\u062a \u0627\u0644\u0639\u0645\u0644<\/strong><\/p>\n<hr \/>\n<p>\u0627\u0644\u0623\u064a\u0627\u0645: \u0627\u0644\u0633\u0628\u062a \u2013 \u0627\u0644\u062e\u0645\u064a\u0633<br \/>\n\u0627\u0644\u062a\u0648\u0642\u064a\u062a : 8:00 \u0635\u0628\u0627\u062d\u0627\u064b \u2013 2.00 \u0645\u0633\u0627\u0621\u064b<\/p>\n[\/mhc_text][mhc_button admin_label=&#8221;\u0632\u0631&#8221; button_url=&#8221;https:\/\/asmarya.edu.ly\/pharmacy\/?page_id=26026&#8243; button_text=&#8221;\u0644\u0644\u062a\u0648\u0627\u0635\u0644 \u0645\u0639\u0646\u0627&#8221; url_new_window=&#8221;off&#8221; button_style=&#8221;off&#8221; button_color=&#8221;#ffffff&#8221; button_text_color=&#8221;#ffffff&#8221; background_layout=&#8221;dark&#8221; use_icon=&#8221;on&#8221; font_list=&#8221;mhicons&#8221; font_mhicons=&#8221;%%31%%&#8221; text_orientation=&#8221;right&#8221; animation=&#8221;off&#8221; button_fx=&#8221;off&#8221; button_size=&#8221;default&#8221; button_font=&#8221;on&#8221; wide_button=&#8221;on&#8221; button_icon=&#8221;off&#8221; use_circle=&#8221;off&#8221; disabled=&#8221;on&#8221;]\n<p>&nbsp;<\/p>\n[\/mhc_button][\/mhc_column][\/mhc_row][\/mhc_section]\n","protected":false},"excerpt":{"rendered":"<p>[mhc_section admin_label=&#8221;\u0642\u0633\u0645&#8221; fullwidth=&#8221;on&#8221; specialty=&#8221;off&#8221;][mhc_fullwidth_texton admin_label=&#8221;\u0645\u0644\u0635\u0642 \u0628\u0639\u0631\u0636 \u0643\u0627\u0645\u0644&#8221; src=&#8221;https:\/\/asmarya.edu.ly\/pharmacy\/wp-content\/uploads\/2026\/03\/\u0648\u0635\u0641-\u0627\u0644\u0645\u0642\u0631\u0631\u0627\u062a-\u0627\u0644\u062f\u0631\u0627\u0633\u064a\u0629-1.webp&#8221; text_placement=&#8221;right_bottom&#8221; text_size=&#8221;xl&#8221; text_color=&#8221;#ffffff&#8221; url_new_window=&#8221;off&#8221; background_color=&#8221;#121212&#8243; text_shadow=&#8221;off&#8221; use_button=&#8221;off&#8221; button_style=&#8221;off&#8221; button_color=&#8221;#0b0b21&#8243; button_text_color=&#8221;#ffffff&#8221; wide_button=&#8221;off&#8221; sticky=&#8221;off&#8221; animation=&#8221;off&#8221; hoverfx=&#8221;scaleup&#8221;] [\/mhc_fullwidth_texton][\/mhc_section][mhc_section admin_label=&#8221;\u0642\u0633\u0645&#8221; fullwidth=&#8221;off&#8221; specialty=&#8221;off&#8221; transparent_background=&#8221;off&#8221; gradient_background=&#8221;off&#8221; background_color=&#8221;#ffffff&#8221; gradient_style=&#8221;horizontal&#8221; inner_shadow=&#8221;off&#8221; parallax=&#8221;off&#8221; parallax_method=&#8221;off&#8221; video_hide=&#8221;off&#8221; video_pause=&#8221;off&#8221; allow_advanced_padding=&#8221;on&#8221; remove_padding=&#8221;on&#8221; force_fullwidth=&#8221;off&#8221; column_paddings=&#8221;padding-0pct&#8221; column_match_heights=&#8221;off&#8221; background_leak=&#8221;off&#8221; background_leak_color=&#8221;#ffffff&#8221; background_leak_size=&#8221;50&#8243; separator_top=&#8221;off&#8221; separator_bottom=&#8221;off&#8221; background_image_size=&#8221;cover&#8221; background_image_repeat=&#8221;no-repeat&#8221; background_image_position_x=&#8221;center&#8221; background_image_position_y=&#8221;center&#8221; animation=&#8221;off&#8221; animation_color=&#8221;#ffffff&#8221; mobile_2_pr_row=&#8221;off&#8221; mobile_reverse=&#8221;off&#8221;][mhc_row admin_label=&#8221;\u0635\u0641&#8221;][mhc_column type=&#8221;4_4&#8243;][mhc_divider [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-26979","page","type-page","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.0 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>\u062a\u0648\u0635\u064a\u0641 \u0627\u0644\u0645\u0642\u0631\u0631\u0627\u062a \u0627\u0644\u062f\u0631\u0627\u0633\u064a\u0629 \u0644\u0642\u0633\u0645 \u0627\u0644\u0631\u0639\u0627\u064a\u0629 \u0627\u0644\u0635\u064a\u062f\u0644\u0627\u0646\u064a\u0629 - \u0643\u0644\u064a\u0629 \u0627\u0644\u0635\u064a\u062f\u0644\u0629<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/asmarya.edu.ly\/pharmacy\/?page_id=26979\" \/>\n<meta property=\"og:locale\" content=\"ar_AR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"\u062a\u0648\u0635\u064a\u0641 \u0627\u0644\u0645\u0642\u0631\u0631\u0627\u062a \u0627\u0644\u062f\u0631\u0627\u0633\u064a\u0629 \u0644\u0642\u0633\u0645 \u0627\u0644\u0631\u0639\u0627\u064a\u0629 \u0627\u0644\u0635\u064a\u062f\u0644\u0627\u0646\u064a\u0629 - \u0643\u0644\u064a\u0629 \u0627\u0644\u0635\u064a\u062f\u0644\u0629\" \/>\n<meta property=\"og:description\" content=\"[mhc_section admin_label=&#8221;\u0642\u0633\u0645&#8221; fullwidth=&#8221;on&#8221; specialty=&#8221;off&#8221;][mhc_fullwidth_texton admin_label=&#8221;\u0645\u0644\u0635\u0642 \u0628\u0639\u0631\u0636 \u0643\u0627\u0645\u0644&#8221; src=&#8221;https:\/\/asmarya.edu.ly\/pharmacy\/wp-content\/uploads\/2026\/03\/\u0648\u0635\u0641-\u0627\u0644\u0645\u0642\u0631\u0631\u0627\u062a-\u0627\u0644\u062f\u0631\u0627\u0633\u064a\u0629-1.webp&#8221; text_placement=&#8221;right_bottom&#8221; text_size=&#8221;xl&#8221; text_color=&#8221;#ffffff&#8221; url_new_window=&#8221;off&#8221; background_color=&#8221;#121212&#8243; text_shadow=&#8221;off&#8221; use_button=&#8221;off&#8221; button_style=&#8221;off&#8221; button_color=&#8221;#0b0b21&#8243; button_text_color=&#8221;#ffffff&#8221; wide_button=&#8221;off&#8221; sticky=&#8221;off&#8221; animation=&#8221;off&#8221; hoverfx=&#8221;scaleup&#8221;] [\/mhc_fullwidth_texton][\/mhc_section][mhc_section admin_label=&#8221;\u0642\u0633\u0645&#8221; fullwidth=&#8221;off&#8221; specialty=&#8221;off&#8221; transparent_background=&#8221;off&#8221; gradient_background=&#8221;off&#8221; background_color=&#8221;#ffffff&#8221; gradient_style=&#8221;horizontal&#8221; inner_shadow=&#8221;off&#8221; parallax=&#8221;off&#8221; parallax_method=&#8221;off&#8221; video_hide=&#8221;off&#8221; video_pause=&#8221;off&#8221; allow_advanced_padding=&#8221;on&#8221; remove_padding=&#8221;on&#8221; force_fullwidth=&#8221;off&#8221; column_paddings=&#8221;padding-0pct&#8221; column_match_heights=&#8221;off&#8221; background_leak=&#8221;off&#8221; background_leak_color=&#8221;#ffffff&#8221; background_leak_size=&#8221;50&#8243; separator_top=&#8221;off&#8221; separator_bottom=&#8221;off&#8221; background_image_size=&#8221;cover&#8221; background_image_repeat=&#8221;no-repeat&#8221; background_image_position_x=&#8221;center&#8221; background_image_position_y=&#8221;center&#8221; animation=&#8221;off&#8221; animation_color=&#8221;#ffffff&#8221; mobile_2_pr_row=&#8221;off&#8221; mobile_reverse=&#8221;off&#8221;][mhc_row admin_label=&#8221;\u0635\u0641&#8221;][mhc_column type=&#8221;4_4&#8243;][mhc_divider [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/asmarya.edu.ly\/pharmacy\/?page_id=26979\" \/>\n<meta property=\"og:site_name\" content=\"\u0643\u0644\u064a\u0629 \u0627\u0644\u0635\u064a\u062f\u0644\u0629\" \/>\n<meta property=\"article:modified_time\" content=\"2026-03-30T07:05:15+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u0648\u0642\u062a \u0627\u0644\u0642\u0631\u0627\u0621\u0629 \u0627\u0644\u0645\u064f\u0642\u062f\u0651\u0631\" \/>\n\t<meta name=\"twitter:data1\" content=\"39 \u062f\u0642\u064a\u0642\u0629\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/asmarya.edu.ly\/pharmacy\/?page_id=26979\",\"url\":\"https:\/\/asmarya.edu.ly\/pharmacy\/?page_id=26979\",\"name\":\"\u062a\u0648\u0635\u064a\u0641 \u0627\u0644\u0645\u0642\u0631\u0631\u0627\u062a \u0627\u0644\u062f\u0631\u0627\u0633\u064a\u0629 \u0644\u0642\u0633\u0645 \u0627\u0644\u0631\u0639\u0627\u064a\u0629 \u0627\u0644\u0635\u064a\u062f\u0644\u0627\u0646\u064a\u0629 - \u0643\u0644\u064a\u0629 \u0627\u0644\u0635\u064a\u062f\u0644\u0629\",\"isPartOf\":{\"@id\":\"https:\/\/asmarya.edu.ly\/pharmacy\/#website\"},\"datePublished\":\"2026-03-29T10:53:16+00:00\",\"dateModified\":\"2026-03-30T07:05:15+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/asmarya.edu.ly\/pharmacy\/?page_id=26979#breadcrumb\"},\"inLanguage\":\"ar\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/asmarya.edu.ly\/pharmacy\/?page_id=26979\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/asmarya.edu.ly\/pharmacy\/?page_id=26979#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"\u0627\u0644\u0631\u0626\u064a\u0633\u064a\u0629\",\"item\":\"https:\/\/asmarya.edu.ly\/pharmacy\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"\u062a\u0648\u0635\u064a\u0641 \u0627\u0644\u0645\u0642\u0631\u0631\u0627\u062a \u0627\u0644\u062f\u0631\u0627\u0633\u064a\u0629 \u0644\u0642\u0633\u0645 \u0627\u0644\u0631\u0639\u0627\u064a\u0629 \u0627\u0644\u0635\u064a\u062f\u0644\u0627\u0646\u064a\u0629\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/asmarya.edu.ly\/pharmacy\/#website\",\"url\":\"https:\/\/asmarya.edu.ly\/pharmacy\/\",\"name\":\"\u0643\u0644\u064a\u0629 \u0627\u0644\u0635\u064a\u062f\u0644\u0629\",\"description\":\"\u0627\u0644\u062c\u0627\u0645\u0639\u0629 \u0627\u0644\u0623\u0633\u0645\u0631\u064a\u0629 \u0627\u0644\u0625\u0633\u0644\u0627\u0645\u064a\u0629\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/asmarya.edu.ly\/pharmacy\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ar\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u062a\u0648\u0635\u064a\u0641 \u0627\u0644\u0645\u0642\u0631\u0631\u0627\u062a \u0627\u0644\u062f\u0631\u0627\u0633\u064a\u0629 \u0644\u0642\u0633\u0645 \u0627\u0644\u0631\u0639\u0627\u064a\u0629 \u0627\u0644\u0635\u064a\u062f\u0644\u0627\u0646\u064a\u0629 - \u0643\u0644\u064a\u0629 \u0627\u0644\u0635\u064a\u062f\u0644\u0629","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/asmarya.edu.ly\/pharmacy\/?page_id=26979","og_locale":"ar_AR","og_type":"article","og_title":"\u062a\u0648\u0635\u064a\u0641 \u0627\u0644\u0645\u0642\u0631\u0631\u0627\u062a \u0627\u0644\u062f\u0631\u0627\u0633\u064a\u0629 \u0644\u0642\u0633\u0645 \u0627\u0644\u0631\u0639\u0627\u064a\u0629 \u0627\u0644\u0635\u064a\u062f\u0644\u0627\u0646\u064a\u0629 - \u0643\u0644\u064a\u0629 \u0627\u0644\u0635\u064a\u062f\u0644\u0629","og_description":"[mhc_section admin_label=&#8221;\u0642\u0633\u0645&#8221; fullwidth=&#8221;on&#8221; specialty=&#8221;off&#8221;][mhc_fullwidth_texton admin_label=&#8221;\u0645\u0644\u0635\u0642 \u0628\u0639\u0631\u0636 \u0643\u0627\u0645\u0644&#8221; src=&#8221;https:\/\/asmarya.edu.ly\/pharmacy\/wp-content\/uploads\/2026\/03\/\u0648\u0635\u0641-\u0627\u0644\u0645\u0642\u0631\u0631\u0627\u062a-\u0627\u0644\u062f\u0631\u0627\u0633\u064a\u0629-1.webp&#8221; text_placement=&#8221;right_bottom&#8221; text_size=&#8221;xl&#8221; text_color=&#8221;#ffffff&#8221; url_new_window=&#8221;off&#8221; background_color=&#8221;#121212&#8243; text_shadow=&#8221;off&#8221; use_button=&#8221;off&#8221; button_style=&#8221;off&#8221; button_color=&#8221;#0b0b21&#8243; button_text_color=&#8221;#ffffff&#8221; wide_button=&#8221;off&#8221; sticky=&#8221;off&#8221; animation=&#8221;off&#8221; hoverfx=&#8221;scaleup&#8221;] [\/mhc_fullwidth_texton][\/mhc_section][mhc_section admin_label=&#8221;\u0642\u0633\u0645&#8221; fullwidth=&#8221;off&#8221; specialty=&#8221;off&#8221; transparent_background=&#8221;off&#8221; gradient_background=&#8221;off&#8221; background_color=&#8221;#ffffff&#8221; gradient_style=&#8221;horizontal&#8221; inner_shadow=&#8221;off&#8221; parallax=&#8221;off&#8221; parallax_method=&#8221;off&#8221; video_hide=&#8221;off&#8221; video_pause=&#8221;off&#8221; allow_advanced_padding=&#8221;on&#8221; remove_padding=&#8221;on&#8221; force_fullwidth=&#8221;off&#8221; column_paddings=&#8221;padding-0pct&#8221; column_match_heights=&#8221;off&#8221; background_leak=&#8221;off&#8221; background_leak_color=&#8221;#ffffff&#8221; background_leak_size=&#8221;50&#8243; separator_top=&#8221;off&#8221; separator_bottom=&#8221;off&#8221; background_image_size=&#8221;cover&#8221; background_image_repeat=&#8221;no-repeat&#8221; background_image_position_x=&#8221;center&#8221; background_image_position_y=&#8221;center&#8221; animation=&#8221;off&#8221; animation_color=&#8221;#ffffff&#8221; mobile_2_pr_row=&#8221;off&#8221; mobile_reverse=&#8221;off&#8221;][mhc_row admin_label=&#8221;\u0635\u0641&#8221;][mhc_column type=&#8221;4_4&#8243;][mhc_divider [&hellip;]","og_url":"https:\/\/asmarya.edu.ly\/pharmacy\/?page_id=26979","og_site_name":"\u0643\u0644\u064a\u0629 \u0627\u0644\u0635\u064a\u062f\u0644\u0629","article_modified_time":"2026-03-30T07:05:15+00:00","twitter_card":"summary_large_image","twitter_misc":{"\u0648\u0642\u062a \u0627\u0644\u0642\u0631\u0627\u0621\u0629 \u0627\u0644\u0645\u064f\u0642\u062f\u0651\u0631":"39 \u062f\u0642\u064a\u0642\u0629"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/asmarya.edu.ly\/pharmacy\/?page_id=26979","url":"https:\/\/asmarya.edu.ly\/pharmacy\/?page_id=26979","name":"\u062a\u0648\u0635\u064a\u0641 \u0627\u0644\u0645\u0642\u0631\u0631\u0627\u062a \u0627\u0644\u062f\u0631\u0627\u0633\u064a\u0629 \u0644\u0642\u0633\u0645 \u0627\u0644\u0631\u0639\u0627\u064a\u0629 \u0627\u0644\u0635\u064a\u062f\u0644\u0627\u0646\u064a\u0629 - \u0643\u0644\u064a\u0629 \u0627\u0644\u0635\u064a\u062f\u0644\u0629","isPartOf":{"@id":"https:\/\/asmarya.edu.ly\/pharmacy\/#website"},"datePublished":"2026-03-29T10:53:16+00:00","dateModified":"2026-03-30T07:05:15+00:00","breadcrumb":{"@id":"https:\/\/asmarya.edu.ly\/pharmacy\/?page_id=26979#breadcrumb"},"inLanguage":"ar","potentialAction":[{"@type":"ReadAction","target":["https:\/\/asmarya.edu.ly\/pharmacy\/?page_id=26979"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/asmarya.edu.ly\/pharmacy\/?page_id=26979#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"\u0627\u0644\u0631\u0626\u064a\u0633\u064a\u0629","item":"https:\/\/asmarya.edu.ly\/pharmacy\/"},{"@type":"ListItem","position":2,"name":"\u062a\u0648\u0635\u064a\u0641 \u0627\u0644\u0645\u0642\u0631\u0631\u0627\u062a \u0627\u0644\u062f\u0631\u0627\u0633\u064a\u0629 \u0644\u0642\u0633\u0645 \u0627\u0644\u0631\u0639\u0627\u064a\u0629 \u0627\u0644\u0635\u064a\u062f\u0644\u0627\u0646\u064a\u0629"}]},{"@type":"WebSite","@id":"https:\/\/asmarya.edu.ly\/pharmacy\/#website","url":"https:\/\/asmarya.edu.ly\/pharmacy\/","name":"\u0643\u0644\u064a\u0629 \u0627\u0644\u0635\u064a\u062f\u0644\u0629","description":"\u0627\u0644\u062c\u0627\u0645\u0639\u0629 \u0627\u0644\u0623\u0633\u0645\u0631\u064a\u0629 \u0627\u0644\u0625\u0633\u0644\u0627\u0645\u064a\u0629","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/asmarya.edu.ly\/pharmacy\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ar"}]}},"_links":{"self":[{"href":"https:\/\/asmarya.edu.ly\/pharmacy\/index.php?rest_route=\/wp\/v2\/pages\/26979","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/asmarya.edu.ly\/pharmacy\/index.php?rest_route=\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/asmarya.edu.ly\/pharmacy\/index.php?rest_route=\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/asmarya.edu.ly\/pharmacy\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/asmarya.edu.ly\/pharmacy\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=26979"}],"version-history":[{"count":7,"href":"https:\/\/asmarya.edu.ly\/pharmacy\/index.php?rest_route=\/wp\/v2\/pages\/26979\/revisions"}],"predecessor-version":[{"id":26987,"href":"https:\/\/asmarya.edu.ly\/pharmacy\/index.php?rest_route=\/wp\/v2\/pages\/26979\/revisions\/26987"}],"wp:attachment":[{"href":"https:\/\/asmarya.edu.ly\/pharmacy\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=26979"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}